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Bovine viral diarrhea virus (BVDV) is an important viral pathogen affecting all ages
of cattle, resulting in significant economic losses worldwide. BVDV infection is associated
with a diverse array of symptoms including gastrointestinal disorder, respiratory distress,
fetal malformation, stillbirth, abortions, and mucosal disease (MD). Transplacental infections
of fetuses between 42 and 125 days of gestation can result in immune-tolerance and the
surviving fetuses become persistently infected (PI). PI animals are major reservoir of BVDV
and it becomes problematic to control the disease. The objectives of this dissertation were to:
1) develop a cost-effective testing scheme to detect BVDV PI animals from exposed herds, 2)
characterize two virulent BVDV-2 Mississippi isolates associated with severe hemorrhagic
diseases, and 3) perform phylogenetic analysis based on sequences of 5'UTR, E2, and NS5B
regions. First, we developed a BVDV testing scheme by combining pooled real-time RTPCR with antigen capture enzyme-linked immunosorbent assay (ACE) to screen cattle herds.
From positive pools individual positives were identified using ACE. Data from a three year
period indicated that 92.94% PI animals were infected with BVDV-1, 3.53% with BVDV-2,
and 3.53% with both BVDV-1 and BVDV-2. Analysis of the 5'UTR of 22 isolates revealed

Template Created By: James Nail 2010

the predominance of BVDV-1b followed by BVDV-2a. Second, two virulent BVDV isolates,
M10-3432 and M10-5347, were successfully recovered from an adult beef breeding cow and
feedlot calf respectively. When compared to the reference strain BVDV-2 125c, five and
three unique amino acids in E2 regions were different from M10-5347 and M10-3432
respectively. Phylogenetic analysis of E2 region grouped both Mississippi isolates in BVDV2a, a subtype containing high virulent strains. M10-3432 was clustered with high virulent
strain 890 while M10-5347 was clustered with high virulent strain CD87. Third, we
compared the phylogenetic analyses of BVDV based on the sequences of 5'UTR, E2, and
NS5B at either nucleotides or amino acids level. Although slight differences were observed,
the virulent BVDV isolates were consistently classified into BVDV-2a cluster regardless of
region of sequences used. Furthermore, phylogenetic tree constructed using combined two or
more regions had higher posterior probability and bootstrap value than phylogenetic trees
constructed using a single region
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CHAPTER I
INTRODUCTION
Bovine viral diarrhea virus (BVDV) is a major viral pathogen of cattle and results
in significant economic losses worldwide by infecting cattle and contaminating biological
products. Classical swine fever virus (CSFV), Border disease virus (BDV), BVDV, and
tentative pestivirus giraffe-1 virus are members of genus Pestivirus of the family
Flavivirdae. BVDV is classified into two biotypes cytopathic (CP) and noncytopathic
(NCP) based on the presence or absence of visible cytopathic effect (CPE) in infected cell
cultures. BVDV is also divided into two genotypes - BVDV-1 and BVDV-2 - based on
genetic variation.
BVDV infection is associated with a diverse array of symptoms including
gastrointestinal disorder, respiratory distress, fetal malformation, stillbirth, abortion, and
mucosal disease (MD). BVDV can infect all ages of cattle including fetuses. Transplacental infections of the fetuses between 42 and 125 days of gestation can result in
immune-tolerance and the surviving fetuses become persistently infected (PI). PI animals
are associated with higher incidence of respiratory diseases and associated risk for
treatment, and PI animals shed a large amount of virus from their body secretions and
excretions as the reservoir of BVDV (McClurkin et al. 1984; Baker 1995; Loneragan et
al. 2005b). Therefore, identification and subsequent removal of PI animal(s) from
exposed herds plays an important role in BVDV prevention and eradication.

1

Clinical manifestations caused by BVDV vary from clinically unapparent to
clinically severe depending on the virulence of the BVDV-2 strains. Most of virulent
BVDV strains belong to BVDV-2 genotype, whereas the avirulent BVDV-2 isolates
occurred more frequently than did the virulent BVDV-2. However, little is known about
the virulence of BVDV-1 strains. Genetic mutations in envelop proteins may lead to
antigenic variations as well as the virulence of BVDV, which complicate the BVDV
diagnosis and prevention. In this study, we isolated two virulent BVDV-2 isolates from
Mississippi herds, which were not detected in fresh tissues using direct fluorescent
antibody. There is a need for evaluating the effectiveness of the commonly used detection
methods for BVDV.
Phylogenetic analysis of BVDV has been widely used for revealing the
evolutionary history of new isolates and classifying them on the basis of the molecular
sequencing data. The highly virulent strains of BVDV associated with hemorrhagic
syndrome discovered in North American in recent years are genotyped as BVDV-2 using
phylogenetic analysis of 5'UTR region. Currently many new computational methods are
available to be used in phylogenetic analysis of BVDV.
The main objectives of this study were:
1)

To develop a BVDV testing scheme by using a combination of real-time

RT-PCR and antigen capture enzyme-linked immunosorbent assay (ACE) for the
detection of persistently infected animals
2)

To characterize two virulent BVDV isolates which were not detectable

using direct fluorescent antibody test from tissue samples of animals with severe clinical
disease and fatal outcome

2

3)

To perform phylogenetic analysis of BVDV based on sequences of 5'UTR,

E2, and NS5B regions

3

CHAPTER II
REVIEW OF LITERATURE
Bovine viral diarrhea virus (BVDV) is a major viral pathogen affecting cattle and
resulting in significant economic worldwide losses. In the 1940s, BVDV was described
as “X disease” in western Canada and as “Bovine viral diarrhea” (BVD) in Cornell
University. Symptoms included severe diarrhea, depression, anorexia, ulceration of oral
mucosa, a high rate of morbidity, and a relatively low rate of mortality (Olafson et al.
1946). BVDV was first classified into the Togaviridae family in the 1970s (Fenner and
Maurin 1976). Together with classical swine fever virus (CSFV), border disease virus
(BDV), and tentative pestivirus giraffe-1 virus, BVDV is classified into the genus
Pestivirus of the Flaviviridae family in the VIIIth report of the International Committee
on the Taxonomy of Viruses (Thiel et al. 2005).
2.1

Physical properties and taxonomy
Pestivirus virions are composed of a lipid bilayer envelop with embedded

transmembrane glycoproteins that surrounded a protein-RNA nucleocapsid with a
diameter of 40-to-60 nm and an inner core with an approximate density of 30-nm
electrons (Zuckerman 1981). Pestiviruses can survive over a relatively broad pH range,
but they can be inactivated by heat, organic solvents, and detergents (Liess 1981;
Rümenapf et al. 1991). BVDV and CSFV were able to be purified at buoyant sucrose of
1.134 g/ml and sediment at 100 Svedberg units (Laude 1987).
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Based on the presence or absence of visible cytopathic effect (CPE) in infected
cell cultures, BVDV is distinguished into two biotypes: cytopathic strain (CP) and
noncytopathic strain (NCP) (Lee and Gillespie 1957). Both CP and NCP BVDV express
the nonstructural proteins (NS) 2-3, but the generation of NS3 strictly correlates with the
CP BVDV (Meyers and Thiel 1996; Kümmerer et al. 2000). BVDV is also classified into
two genotypes - BVDV-1 and BVDV-2 - based on the genetic variation (Ridpath et al.
1994b). BVDV-1 was isolated more frequently from cattle with respiratory symptoms
than BVDV-2 (Fulton et al. 2000). In early studies, BVDV-1 was typed into two groups
- BVDV-1a and BVDV-1b - in the USA and Canada (Pellerin et al. 1994; Ridpath and
Bolin 1998). With the increase of new BVDV-1 isolates, BVDV-1 was classified into at
least 11 genetic groups around the world based on the phylogenetic analysis of 5'untranslated region (5'UTR) and N-terminal protease fragment (Npro) (Vilcek et al. 2001).
BVDV-1b can be clustered further into 1b1 and 1b2 subtypes based on the variation of
E2. Strains CP7 and NY1 were clustered into 1b2, whereas Osloss strain was clustered
into 1b1. The predominant BVDV-1b strain is 1b2 in the United States, and there has
been relatively small change of 1b2 during a 50-year period (Tajima and Dubovi 2005).
Based on the genetic variation of 5'UTR and NS2/3, BVDV-2 was typed into two groups
2a and 2b (Flores et al. 2002). However, symptoms vary from clinically unapparent to
clinically severe depending on the virulence of the BVDV-2 strains. The hemorrhagic
syndrome of BVDV infections was associated with BVDV-2; however, the CPE of
BVDV does not correlate with virulence. In nature, the avirulent BVDV-2 isolates
occurred more frequently than did the virulent BVDV-2 (Ridpath et al. 2000). New
BVDV-2 isolates were identified from South America, and these new isolates were typed
into 2b, 2c, and 2d. Limited sequence information exists for 2c and 2d (Giangaspero et al.
5

2008). BVDV-1a, BVDV-1b, and BVDV-2a are major genotypes isolated in North
America (Ridpath et al. 2000; Ridpath 2010).
2.2

Molecular characteristics
The BVDV genome is single-stranded and positive-sense RNA with ~12.5 kb,

possesses a single open reading frame (ORF), and encodes about 4000 amino acids. The
BVDV long ORF was flanked by 5'UTR (372-385 nucleotides in length) and 3'UTR
(229-273 nucleotides in length) (Collett et al. 1988b; Lindenbach et al. 2007) . The
BVDV genome lacks a cap structure at 5' terminus and terminates with a short poly (C)
instead of a poly (A) at 3' terminus (Brock et al. 1992). Among coding regions, the first
third of the ORF encodes an autoprotease Npro and four structural proteins C, Erns, E1, E2,
while the 3' end of the RNA genome encodes the other presumably nonstructural
proteins: p7, NS2-3, (NS2), (NS3), NS4A, NS4B, NS5A, and NS5B (Meyers and Thiel
1996; Lindenbach et al. 2007) (Figure 2.1).

Figure 2.1

BVDV genome structure

Pestivirus-unique nonstructural protein Npro refers to an N-terminal autoprotease
that is released from the polyprotein precursor, and pestivirus-unique envelope
glycoprotein Erns refers to the RNase activity (Wiskerchen et al. 1991; Ridpath and Bolin
6

1995). The activity of host signal peptidases gives rise to C, Erns, and E2, which are
destined to form the capsid and the envelope of the virion (Lindenbach et al. 2007). Both
E1 (gp33) and E2 (gp55) are integral membrane proteins, which contain two-to-three and
four-to-six N-linked glycosylation sites, respectively (Weiland et al. 1990). The
glycoproteins Erns, E1, E2 are composed of the envelope of BVDV, and the Erns and E2
form a disulphide-linked homodimer. E1 is associated with E2 by forming a heterodimer,
and E1 is assumed to be a membrane anchor of E2. All glycoproteins - Erns, E1, and E2 are associated with virus attachment and/or cell entry (Weiland et al. 1990; Rümenapf et
al. 1993b). Both CP and NCP BVDV express NS2-3, but the generation of NS3 strictly
correlates with the CP phenotype. The study of the genetic characterization of NCP-CP
pairs indicates that most CP BVDV strains are generated from NCP pestivirus by RNA
recombination (Meyers et al. 1996; Pellerin et al. 1995). RNA recombination includes
host cell derived insertions, sometimes combined with large duplications or deletions of
viral sequences (Meyers et al. 1996). NS3 possesses multiple enzymatic activities - serine
protease, NTPase, and helicase activity - and NS5B represents the RNA-dependent RNA
polymerase (RdRp) (Pankraz et al. 2005). Two hydrophobic proteins, NS4A and NS4B,
are similar in size and composition. NS4A possesses serine protease cofactor activity (Xu
et al. 1997), and NS4B associates with the rearranged host membranes and Golgi
apparatus (Weiskircher et al. 2009). A large and hydrophilic phosphor-protein, NS5A,
possesses the zinc-binding properties required for RNA replication (Tellinghuisen et al.
2006). Replication of the virus genome occurs in the cytoplasm of the infected cell along
with the translation process. The virus-encoded RdRp of NS5B is necessary for the
replication of the RNA genome, and RdRp is a key enzyme among members of the virus
family Flaviviridae (Steffens et al. 1999).
7

2.3

Replication, transcription, assembly, and release of virus particles
BVDV infection of the host cell involves multiple steps, including the attachment

of virions, interaction with specific receptors, internalization, and membrane fusion
(Hulst and Moormann 1997; Liang et al. 2003; Lecot et al. 2005). BVDV replication
takes place in the cytoplasm; the viral RNA functions as a messenger RNA in the
cytoplasm of the host cell and directs the synthesis of an unstable polyprotein which is
co- and post-translational processed into at least 11 mature structural and nonstructural
viral proteins (Gray and Nettleton 1987; Collett et al. 1988a; Rümenapf et al. 1993a;
Rümenapf et al. 1993b). BVDV enters the host cell by clathrin-dependent receptormediated endocytosis and decapsidation of the nucleocapsids; the viral genome serves as
a template for the translation of viral proteins (Poole et al. 1995; Grummer et al. 2004).
No cap structure exists among pestiviruses, which rely on internal ribosomal entry sites
(IRES) of 5'UTR to mediate the initiation of translation. The 5'UTR contains essential
structural or functional components that may extend into nucleotide sequences within the
ORF, and three domains and a pseudoknot structure are required for IRES activity (Gong
et al. 1996; Lindenbach et al. 2007). During the translation of Pestivirus, nonstructural
proteins assemble into a functional replicate complex to catalyze transcription of
positive-sense RNA into complementary strand negative-sense RNA, which provides a
template for the replicate complex to synthesize nascent positive-sense RNA using a
semi-conservative asymmetric replication model (Warrilow et al. 2000). The model
includes three virus-specific RNAs: a double-stranded replicative form (RF), a partially
single-stranded and partially double-stranded replicative intermediate form (RI), and a
single-stranded viral RNA. The process of BVDV replication begins with a positive
strand replicate complex comprised of viral and cellular components formed at the 3’
8

terminus of the genome (Hietala and Crossley 2005). Through semi-conservative
asymmetric replication, BVDV replication can be detected in cell culture models within
four-six hours of infection by the finding of negative-strand RNA and nascent positivestrand RNA. The peak of BVDV titer is detected at 12-24 hours post-infection (Gong et
al. 1996).
Little information is available on the assembly and release of virions from
infected cells. Electron microscopic examination shows that BVDV virions appear to
mature in intracellular vesicles and are released through exocytosis (Gray and Nettleton
1987; Hietala and Crossley 2005; Lindenbach et al. 2007).
2.4

Pathogenesis of BVDV infections
BVDV has two biotypes, CP and NCP, and two genotypes, BVDV-1 and BVDV-

2. A study screening cattle with respiratory disease indicates that NCP BVDV was
isolated more frequently than was CP BVDV, and BVDV-1 genotypes were isolated
more frequently than BVDV-2 genotypes in cattle with respiratory disease, based on
necropsy samples of calves with fibrinous pneumonia (Fulton et al. 2000).
BVDV infection is associated with a diverse array of manifestations, including
gastrointestinal disorders, respiratory distress, fetal malformations, stillbirth, abortions,
persistent infections (PI), and mucosal disease (MD) (Baker 1995). BVDV can cross the
placenta and infect fetuses of all ages, and the result of infection varies depending on the
stage of gestation in which infection occurs. Trans-placental infections of a fetus between
42 and 125 days of gestation can result in abortion, stillbirth, weak calf, and immunetolerance. The calf’s immature immune system lacks the ability to recognize the
persisting NCP virus as foreign, and the animals are considered immune tolerant. If a
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fetus survives after infection, they will develop as animals persistently infected by BVDV
and will not produce neutralizing antibodies (McClurkin et al. 1984). Fetal exposure to
BVDV before 42 days of gestation may result in embryonic death, and cattle infected
with BVDV during this period will have lower fertility than non-infected cattle (MuñozZanzi et al. 2004). Conversely, exposure after day 125 of gestation may result in a fetus
that is able to mount an immune response to a BVDV infection because the immune
system develops during the later stages of gestation (McClurkin et al. 1984).
Persistently infected animals, reservoirs of BVDV, continually shed large
amounts of virus throughout their lives via body secretions and excretions (McClurkin et
al. 1984; Baker 1995; Loneragan et al. 2005). Although CP BVDV is able to cross the
placental, PI animals were caused with the infection of NCP BVDV strain. Most BVDV
isolates are NCP but yield CP variants after repeated passage in cell culture, but NCP
BVDV appeared to cause abortion more readily than did the CP BVDV (McClurkin et al.
1984; Brownlie et al. 1989).
Acute infection of BVDV ranges from subclinical to highly fatal depending on the
viral strain, host immune status, host reproductive status, and the presence of other
pathogens. In most cases, NCP viruses cause the acute BVDV infections (McClurkin et
al. 1984; Houe 1999). Virus isolation is generally possible between three and ten days
post-infection. Most clinical results are mild following the acute infection, which
includes diarrhea (most of time present following acute infection) and leucopenia.
In the late-1980s, a severe hemorrhagic syndrome in adult cattle and veal calves
was reported in several countries, and this severe hemorrhagic syndrome was associated
with NCP BVDV without an accompanying CP strain. This BVDV hemorrhagic
syndrome was characterized by fever and marked thrombocytopenia resulting in bloody
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diarrhea, epistaxis, petechial and ecchymotic hemorrhages on mucosal surfaces, and
bleeding from infection sites (Corapi et al. 1989).
Mucosal disease is the most severe disease associated with BVDV infection and is
usually fatal; it often occurs between the ages of six months and two years (Baker 1995).
Persistent infected animals are immunotolerant and recognize BVDV as self-antigens.
When NCP PI animals were superinfected with CP BVDV that matches the antigen
pattern of the NCP, the PI animals will develop mucosal disease. Therefore, both CP and
NCP biotypes of BVDV can be isolated from mucosal disease (McClurkin et al. 1984).
2.5

Virulence
The most virulent BVDV strains were characterized as the BVDV-2 genotype,

and limited information is available regarding the virulence of BVDV-1 strains (Bolin
and Ridpath 1992; Corapi et al. 1989; Pellerin et al. 1994; Ridpath et al. 2007). BVDV-2
was isolated from bovine with hemorrhagic syndrome characterized by thrombocytopenia
and high mortality (Rebhun et al. 1989; Bolin and Ridpath 1992; Pellerin et al. 1994) and
bovine with mild clinical forms (Topliff and Kelling 1998). Research indicated that the
hemorrhagic syndrome caused by BVDV-2 is noncytopathic; therefore, the virulence of
BVDV is not associated with cytopathic effect in vivo (Ridpath et al. 2000). Highly
virulent BVDV infections associated with fever, pneumonia, diarrhea, abortion, death,
and hemorrhages on mucosal surfaces and various internal organs have been reported
among all ages of cattle in North America (Corapi et al. 1989; Alves et al. 1996).
Compared to the highly virulent infection, the low virulence isolates caused mild
respiratory tract diseases without diarrhea (Odeon et al. 1999; Kelling et al. 2002). Calves
infected with highly virulent BVDV-2 isolates (23025 or 17583) develop more noticeable
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lesions and more severe signs of clinical disease than do calves inoculated with low
virulence BVDV-2 such as 713, 5521, or 17011 isolates (Kelling et al. 2002). BVDV
infection forms were recognized as mucosal disease, chronic BVD (a form of MD), mildacute BVD, and severe BVD. BVDV-2 high virulence isolates were isolated from severe
acute BVDV infections in North America in the early 1990s. BVDV-2 strains 1373
(NCP) and p24515 were involved in the Ontario epidemic, and strain IAF_103 was
involved in the Quebec epidemic. BVDV-2 NY93 was isolated from the severe acute
BVDV outbreak of a dairy herd in New York in 1993 (Corapi et al. 1989; Pellerin et al.
1994; Ridpath et al. 1994a). BVDV-2 CD87 was isolated from a severe acute BVD
outbreak in New York, and its infection was associated with high fever, bloody diarrhea,
hemorrhages, and prolonged bleeding from venepuncture sites (different from severe
acute BVD, called hemorrhagic syndrome) (Corapi et al. 1989). BVDV-2 strain 890
(NCP) was also isolated from a yearling heifer in Canada that died with extensive internal
hemorrhages (Bolin and Ridpath 1992). BVDV-2 strain JZ05_1 was a low virulence and
cytopathic strain isolated in China (Li et al. 2010a), and limited information is available
regarding the virulence of BVDV-1 strains
The translation efficiency of high virulence isolates is greater than low virulence,
resulting in variation in the regulation of transcription and translation between high
virulence and low virulence isolates. Primary and secondary structure differences may
influence the translation efficiencies (Topliff et al. 2005). Unlike DNA motifs, RNA
motifs are more conserved in structures than they are in sequences. The conserved region
of pestiviruses 5'UTR contains the IRES (Goens 2002), which is involved in the capindependent translation initiation of viral RNA (Rijinbrand et al. 1997). The 3'UTR also
harbors primary and secondary RNA structures, which probably function in cis to direct
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minus-strand initiation (Yu et al. 2000; Isken et al. 2004; Pankraz et al. 2005). The
genome structure and mechanism of viral translation initiation in pestivirus shows strong
similarity with Picornaviridae (Poole et al. 1995). Research of the 5'non coding region of
poliovirus, a member of Picornaviridae, indicates that point mutation within the one stem
loop of an RNA structure is sufficient to attenuate the neurovirulence of poliovirus
(Skinner et al. 1989; Stewart and Semler 1998). Secondary structure analysis of the
5'UTR of BVDV divides the region into four domains: I-IV (NADL as the reference).
Domain I spans from one to 70 (Ia and Ib), domain II spans 77-140, domain III spans
153-323, and domain IV spans from 370-385 (Brown et al. 1992). The proper folding of
the Ia structure is important to the initiation of efficient translation. However, Ia motif is
not critical for RNA replication. The stem of this structure is constituted mainly of
conserved nucleotides of pestivirus, but the loop region is predominantly composed of
variable residues (Yu et al. 2000).
High virulence BVDV-2 was reported and characterized as NCP based on its
activity in cultured epithelial cells (Bolin and Ridpath 1992). Research indicates that the
5'UTR of BVDV relates to the virulence among BVDV-2 genotype; two nucleotide
positions, 219 and 278, were identified in the internal ribosomal entry site that
distinguishes the high virulence from the low virulence genotype 2 isolates. The low
virulence strains have a cytosine (C) and a uracil (U), respectively. However, the high
virulence strains have a U and a C, respectively. The substituted bases are virulence
markers used to differentiate BVDV-2 isolates (Topliff and Kelling 1998).
The activity of host signal peptidases gives rise to C, Erns, and E2, which are
destined to form the capsid and the envelope of the virion (Lindenbach et al. 2007). The
glycoproteins Erns, E1, and E2 are composed of the envelope of BVDV, and the Erns and
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E2 form a disulphide-linked homodimer. E1 is assumed to be a membrane anchor for E2,
all glycoproteins Erns, E1, and E2 are associated with virus attachment and/or cell entry
(Weiland et al. 1990; Rümenapf et al. 1993a). E2 is composed of approximately 370
amino acids, which are the immunodominant protein (Weiland et al. 1990; Hulst and
Moormann 1997). E1 is associated with E2 by forming a heterodimer, which depends on
the charged residues of transmembrane domains and is essential for virus entry (Ronecker
et al. 2008). CSFV and BVDV share a common E2 receptor or co-receptor for binding
and entry of these pestiviruses because recombinant CSFV E2 can bind to cells and block
infection of CSFV and BVDV (Hulst and Moormann 1997). Research of the CSFV
indicates that the structural protein E2 is the virulence factor of CSFV, which was proven
by constructing the infectious clone without E2 to generate an attenuated strain (Risatti et
al. 2005). Both the carboxyl terminal region of E2 and the N-linked glycosylation of E2
influence the virulence of CSFV Brescia strain in swine (Risatti et al. 2007). The most
variable protein of pestiviruses is immunodominant protein E2, which is the location of
the majority of neutralization epitopes and PCR, tested to differentiate pestivirus species.
This highly variable region of E2 is suitable for identifying and classifying pestiviruses
(Meyers and Thiel 1996; Mingala et al. 2009).
2.6

Diagnostic Methods
BVDV is a major viral pathogen that affects cattle. It causes significant economic

losses worldwide by infecting cattle and contaminating biological products. BVDV viral
antigens were found in epithelial cells at the site of entry, endothelial cells,
lymphoreticular cells, and macrophages. BVDV can be detected from most tissues,
including peripheral blood mononuclear cells (PBMC), the gastrointestinal tract, and
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neurons (Lindenbach et al. 2007). BVDV can be detected from tissue, serum, semen, and
somatic cells of milk (Afshar et al. 1991; Schmitt et al. 1994; Radwan et al. 1995;
Renshaw et al. 2000; Beaudeau et al. 2001; Driskell and Ridpath 2006).
As instances of BVDV infection and subsequent economic losses increase,
detection of the pathogen becomes essential to prevent and eradicate BVDV infections.
Different diagnostic methods have been developed based on antibodies, antigens, and
nucleic acid at both the herd and individual level. BVDV has been detected through spot
hybridization with probes prepared from cloned cDNA sequences and RNA hybridization
(Potgieter and Brock 1989; Roberts et al. 1991). BVDV has also been detected using
enzyme-linked immunosorbent assay (ELISA), virus isolation (VI),
immunohistochemistry (IHC), serum neutralization (SN), and direct and indirect
fluorescent assay (FA) (Afshar et al. 1991; Cornish et al. 2005; Roberts et al. 1988;
Schmitt et al. 1994; Saliki et al. 1997; Weiland et al. 1990). PCR amplification was
developed to detect BVDV from bulk milk samples; and single-tube single-enzyme RTPCR, TaqMan PCR, and real time RT-PCR were used to identify BVDV from tissue,
serum, semen, and milk (Weinstock et al. 2001; Mahlum et al. 2002; Bhudevi and
Weinstock 2003; Baxi et al. 2006; Daliri et al. 2007).
Among the variety of diagnostic methods, however, VI is still perceived as the
gold standard, but it is laborious, time-consuming, and unsuitable for whole-herd testing
(Saliki et al. 1997; Renshaw et al. 2000). VI detection relies on the existence of viable
virus in tissues. Autolysis, especially for aborted fetuses or stillborn calves, reduces the
recovery of live viruses, which can lead to false negative results (Ellis et al. 1995;
Ridpath et al. 2009). PCR detection is 14.6 times more sensitive than virus isolation in
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detecting BVDV RNA in the purified milk somatic cells of PI animals (Radwan et al.
1995).
A variety of ELISA diagnostic tests have been developed and widely used to
detect BVDV from serum, or the presence of antigen from ear notch tissue, milk, etc.
(Cornish et al. 2005). ELISA is suitable for screening samples in large volumes due to its
time savings, but the cost for testing individual animals is relatively high (Schmitt et al.
1994; Driskell and Ridpath 2006). Although VI and ELISA seem sufficient to identify PI
among older animals, the colostral antibodies may interfere with both methods for
detection of BVDV in young calves, especially for serum testing. PCR is a nucleic acid
based assay, which should not be subjected to interfere from colostral antibodies, and
may be a better method for screening young PI calves. Colostral antibodies in PI animals
decline rapidly, and they will be absent by the time a calf reaches two months of age.
Available VI negative and PCR-positive calves are retested for BVDV at or after this age.
Generally, the recommendation stands that calves younger than three months tested by VI
should be retested again at three months (Brinkhof et al. 1996; Brock et al. 1998). Realtime RT-PCR has been widely accepted to identify, type, and detect BVDV from pooled
samples due to its specificity, high sensitivity, and rapid turnaround time (Letellier and
Kerkhofs 2003; Yan et al. 2011).
IHC detection is limited to tissue samples, which must be fixed using formalin
and embedded using paraffin. Therefore, IHC detection normally takes three to four days;
such length of time is inappropriate for urgent cases. ACE is performed on fresh skin (ear
notch) specimens, and IHC is performed on skin specimens fixed in neutral-buffered 10%
formalin, but real-time RT-PCR and VI can be performed on both tissue and serum
samples.
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Rapid tests, such as ACE, permit identification and segregation of PI cattle
pending results of further tests, which reduces the animal's contact with the rest of the
feedlot population. Cattle that are vaccinated with BVDV-1a and 2a may not induce
adequate protective immunity against BVDV. Therefore, control of BVDV necessitates
an enhancement of immunity against BVDV through vaccination and biosecurity by
identification and removal of PI cattle. This process will maintain the BVDV-negative
status among the animal population. A rapid test for detection of PI cattle may be
beneficial so that PI cattle can be removed as quickly as possible from the feedlot,
minimizing continuous exposure to BVDV. Compared with the cost of VI and real-time
RT-PCR on individual samples among a population, IHC and ACE are cost friendly.
However, ACE can be accomplished in less than five hours of laboratory time, rather
than three to five days for IHC. This quick turnaround time allows animals to be removed
sooner and lessens the potential threat of acute infection. Moreover, ACE provides totally
objective results, whereas IHC is subjective and has the potential for misinterpretation
from inexperienced pathologists.
2.7

Phylogenetic analysis
Phylogenetic analysis of pestivirus has been widely used to genotype the new

isolates and to study their evolutionary history. Multiple ways have been used to infer the
phylogeny of a species, they all fall into two fundamental approaches to construct the
phylogenetic tree by either single genetic element or concatenating multiple genetic
sequences (de Queiroz et al. 1995; Gadagkar et al. 2005; Huelsenbeck et al. 1996; Nei et
al. 2001; Yang 1996). Different genomic regions of pestivirus have been used to type
new isolates and 5'UTR is the most commonly used (Pellerin et al. 1994; Baule et al.
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1997; Wolfmeyer et al. 1997; Ridpath et al. 2000; Vilcek et al. 2003); Npro (Vilcek et al.
2001), E2 (Mingala et al. 2009; Oguzoglu et al. 2010), NS3 (Xia et al. 2007), and NS5B
are also used to phylogenetic analysis (Nagai et al. 2004). 5'UTR harbors internal
ribosomal entry site, which is highly conserved among all members within the genus
pestivirus, thus being used extensively for the characterization of BVDV genotypes
(Pestova et al. 1998). Immunodominant protein E2 is the location of the majority of
neutralization epitopes, and therefore E2 can as the target for serological tests to
differentiate pestivirus species. BVDV can be classified into two genotypes BVDV-1 and
BVDV-2 based on the genetic variations of 5'UTR (Ridpath et al. 1994). BVDV-1 can
be further divided into at least 11 subtypes (1a to 1l) based on the phylogenetic analysis
of 5'UTR and Npro (Jackova et al. 2008; Vilcek et al. 2001) while BVDV-2 can be
divided further into four subtypes BVDV-2a, BVDV-2b, BVDV-2c, and BVDV-2d
(Giangaspero et al. 2008). BVDV-1a, 1b and 2a are the major subtypes in North America
(Ridpath 2010).
Secondary structure prediction and phylogenetic analysis are the most common
methods for the classification of the pestivirus isolates. Sequence alignment is the basis
of the phylogenetic analysis, and sequence alignment is also important for the prediction
of consensus structure from multiple sequences. Sequence alignment indicates the
differences between two (pair-wise alignment) or more (multiple-alignment) sequences
by searching individual characters or patterns of the sequences. Multiple sequence
alignment (MSA) has been used to identify the conserved sequence region or to establish
the evolutionary history by aligning a set of three or more sequences (Wang and Jiang
1994). Progressive alignment and iterative alignment are commonly used in MSA.
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Different programs were developed to perform MSA, such as ClustalW, T-coffee, Muscle
(Notredame et al. 2000; Edgar 2004; Larkin et al. 2007), and others.
The evolutionary history of genes and species can be revealed by using the
phylogenetic tree, which is also used in viral classification. Phylogenetic trees include
rooted trees and unrooted trees, and rooted trees can tell the common ancestor.
Phylogenetic trees can be constructed using four methods: distance, maximum
parsimony, maximum likelihood, and Bayesian. The distance approach is based on the
genetic distance of sequences, but this method is unable to use local high-variation
regions effectively (Mount 2004). Both neighbor-joining (NJ) and un-weighted pair
group method with arithmetic mean (UPGMA) use distances between sequences to
construct the phylogenetic tree (Saitou and Nei 1987; Murtaugh 1992). Nonetheless, the
constant rate of evolution (molecular clock hypothesis) assumed in UPGMA is not
appropriate for inferring relationships. UPGMA is no longer commonly used to establish
phylogenetic trees.
The phylogenetic tree produced from maximum parsimony is the tree with the
least evolutionary change or the least position changes between sequences. Maximum
parsimony is a very simple and popular method appropriate for use with highly similar
sequences and small group sequences. But maximum parsimony cannot guarantee the
statistical consistency necessary to produce the high probability phylogenetic tree
(Felsenstein 1978).
The phylogenetic tree with the highest probability or likelihood can be found
using maximum likelihood. Maximum likelihood has lower variance than other methods
because it evaluates different tree topologies and uses all sequence information fully.
Maximum likelihood is also robust to many violations of the assumption in the
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evolutionary model, and it outperforms all other methods, such as parsimony or distance
methods. However, maximum likelihood consumes much time and memory, and the
result is dependent on the model of evolution used (Aldrich 1997; Cam 1990). Moreover,
the phylogenetic trees constructed using distance methods, maximum parsimony, and
maximum likelihood was supported using bootstrap analysis (Felsenstein 1978).
Bayesian inference is another phylogeny approach and can be performed using
the MrBayes. The reliability of Bayesian inference was estimated using posterior
probabilities, which was approximated using a simulation technique: Markov chain
Monte Carlo (Ronquist and Huelsenbeck 2003; Mar et al. 2005). Bayesian allows
implementation of complex parameter-rich evolution models whereas maximum
likelihood does not.
Phylogenetic analysis can be performed on the single gene or concatenated on
multiple genes. Phylogeny inference from a set of species is known as the species tree,
and the phylogeny inference from gene(s) is called the gene tree. Phylogenetic trees can
be established from concatenating multiple genes into a super-gene alignment, which is
then analyzed to generate the species tree. Phylogenies are also inferred separately from
each gene, and consensus of these gene phylogenies is used to represent the species tree.
2.8
2.8.1

Secondary structure prediction
RNA secondary structure prediction
RNA secondary structure analysis is an important approach in efficient structure

prediction, and it will supply the important guides for biological investigations. For
example, mRNA secondary structure prediction is able to identify in vivo binding sites of
RNA-binding proteins (Li et al. 2010b). The 5�UTR of pestivirus possesses the IRES,
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which is conserved among all members of pestiviruses and involved in the translation
initiation of the viral genome. BVDV 5�UTR harbors extensive RNA structure motifs,
which are related with cap-independent translation initiation and replication of viral
RNA. RNA secondary structure is composed of duplexes, stems, hairpins, internal loops,
bulge loops, and junctions. The secondary structure fold of RNA is based on base pairing
using hydrogen bonds between complementary RNA nucleotides: G:C, A:T, and G:U.
With the development of computational methods, secondary structure prediction
falls into two general categories: one uses multiple sequence alignments to predict
consensus structure and the other predicts the structure of a single sequence. For multiple
sequences, the comparative sequence analysis was used to predict the consensus
structures of a group of sequences by base-pairing canonical pairs common to multiple
sequences. This method is efficient when multiple homologous sequences are available
(Pace et al. 1999). For single sequences, dynamic programming algorithms are used to
predict the secondary structure to minimize free energy. The most popular algorithm is
the minimum free energy (MFE) method, which has been used in the Mfold and
RNAfold to predict the secondary structure of a single sequence (Zuker and Stiegler
1981; Hofacker et al. 1994). The accuracy of secondary structure predictions from a
single sequence is limited using free energy minimization because of the incomplete free
energy values listed in nearest neighbor models, the failure of conformity with the
thermodynamic minimum due to unknown RNA folds, and multiple biologically active
conformations of some RNA sequences (Zuker 2003). However, identification of the
conserved structure using phylogenetic information may be helpful to remedy this defect.
RNA motifs are more conserved in structures than in sequences. Therefore, the
consensus structure of a set of homologous or functionally related RNA sequences may
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represent the RNA motifs, which may provide a deeper insight of regulator activities.
Currently, three approaches can be used to predict consensus secondary structures:
approach A, a consensus secondary structure was inferred from the evolutionary and
energetic information of sequence alignment; approach B, simultaneously align and infer
a consensus structure using “Sankoff algorithm”; and approach C, align the secondary
structures to infer the consensus structure. Among these three approaches, approach A is
the most successful approach, but it is limited by the accuracy of the alignment.
Approach B is time-consuming and requires extreme memory, and approach C is limited
to the existence of a reliable structure (Gardner and Giegerich 2004). Generally, the
secondary structure may contain pseudoknots, which are ignored by most tools due to the
complexity and scarcity of these motifs. Therefore, some programs as described below
were designed to predict the secondary structure with pseudoknots.
Web based server programs which can predict consensus RNA secondary
structures from an RNA alignment such as loops, stems, and pseudoknots. Web based
servers are able to predict consensus structures:
Pfold. Pfold integrates both the energy-based and evolution-based approaches to
predict the folding of multiple aligned RNA sequences. The former depends on the
physical properties of single sequences, while the latter uses evolutionary information in
the form of compensatory base pair substitutions. Pfold was able to fold an alignment
with fewer than 40 sequences, 500 nucleotides in length (Seemann et al. 2008).
Probabilistic evolutionary and thermodynamic (PETfold). PETfold was developed
by combining evolutionary and thermodynamic information in one probabilistic model to
predict consensus RNA secondary structure from an RNA alignment. PETfold is better
than Pfold and RNAalifold because of its wide range of parameter settings. The default
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parameters of PETfold is thought to be a reasonable approximation for the RNA family
alignments with different levels of diversity (Seemann et al. 2011).
RNAalifold. RNAalifold predicts consensus structure with a pseudoknot from
aligned RNA sequences by calculating their minimum free energy (MFE), partition
function (pf), and base pairing probability matrix. Clustal format alignment will be
acceptable in the RNAalifold, which is a part of Vienna package. The original
RNAalifold combines thermodynamic energy minimization with a simple scoring model
to assess evolutionary conservation. Gaps within unpaired regions are simply ignored
because the alignment positions appear as indices and loop sizes. RNAalifold
performance has now been improved to treat gaps more accurately and evaluate
covariation of a sequence using an elaborate model. The improved performance does not
dramatically change implementation and has negligible extra computational cost
(Bernhart et al. 2008).
Comparing RNA secondary structure is a key in bioinformatics when analyzing
the functional similarities of different RNA secondary structures. Dot bracket notation is
the dominant RNA secondary structure format. Dot represents unpaired bases and
brackets represent base pairs in RNA stems, both dot and bracket notations have become
an unofficial standard.
2.8.2

Protein secondary structure prediction
Regulatory functions related to RNA performance were formerly assigned only to

proteins. These functions are also associated with evolutionary conserved motifs that
contain specific sequence and structure properties (Huelsenbeck et al. 1996).
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The primary sequence of protein is a polypeptide chain, which is composed of
amino acids using peptide bonds. The spatial arrangement of these amino acids will form
the secondary structure of a protein. Protein secondary structures are composed of alpha
helices, beta strands, beta sheets, loops, and coils. Secondary structure prediction of a
protein is helpful for tertiary structure prediction.
Structural protein E2 of BVDV is the main target of the BVDV neutralizing
antibody, and E2 is related to BVDV virulence (Collett et al. 1988a; Driskell and Ridpath
2006; Risatti et al. 2007). Understanding the secondary structure of E2 may be helpful in
identifying the relatedness of E2 and BVDV virulence. X-ray crystallography and NMR
are two major experimental methods for determining protein structures. However, both
methods are time consuming and incapable of satisfying the needs of increased protein
sequences. Therefore, efficient prediction programs were developed to predict the
secondary structure of proteins.
Protein secondary structure prediction approaches were developed based on
simple stereochemical or statistics principles in the 1970s (Lim 1974; Chou and Fasman
1974; Garnier et al. 1978). With the development of secondary structure prediction
approaches, pattern matching, homology or nearest neighbor, neural network,
evolutionary methods, and combined approaches have been used in protein secondary
structure prediction (Taylor 1988; Rost 1996; Levin 1997; Jones 1999). Protein
secondary structure prediction programs have been extended to predict structures from a
single sequence to a sequence alignment.
Chou-Fasman. As an empirical approach, Chou-Fasman was developed using
statistical principles and was developed originally in the 1970s. This method predicts
protein secondary structures by analyzing relative frequencies of amino acid in alpha
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helices, beta sheets, and turns based on known structures. The application of ChouFasman has been limited because of low accuracy (55%), lacking account of long-range
information, and assumption of simple additive probability (Chou and Fasman 1974).
Web based server programs which can predict protein secondary structures such
as α-helix, β-sheet and coils. Below are web server approaches with accuracy of more
than 70% in predicting protein secondary structure.
PredictProtein. PredictProtein is a widely used automatic web server for protein
secondary structure prediction. PredictProtein was developed based on neural network
with accuracy of more than 72% (Rost 1996; Rost et al. 2004).
JPred. JPred is a web server for predicting consensus protein secondary structures
based on evolutionary information. This approach simplifies the algorithms and identifies
the conservation patterns that are associated with structure and function. Consensus
structure predictions from JPred improve the prediction accuracy (Q3), which indicates
the total accuracy for all alpha helix, beta strand, and coil. JPred is a well-defined
secondary structure prediction program for single sequences and multiple sequences with
accuracy of up to 7375% (Cuff et al. 1998).
SAMT02. SAM-T02 is a Hidden Markov model (HMM)-based protein
secondary structure prediction program with accuracy of up to 75%. However,
SAMT02 is only able to process one sequence at a time and the amino acids must all be
in upper case (Karplus et al. 2003).
PSIPRED. The PSIPRED server incorporates three methods  PSIPRED,
GenTHEADER, and MEMSAT2  to predict the protein secondary structure from amino
acid sequences. PSIPRED is a highly accurate approach that incorporates two feedforward neural networks. The performance of these programs was evaluated using
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stringent cross-validation procedure. PSIPRED is a highly accurate approach with an
average Q3 score of 76.5% (McGuffin et al. 2000).
2.9

Control, prevention, and vaccination
BVDV can be transmitted through horizontal and genetic vertical transmission.

Horizontal transmission occurs by direct contact with a BVDV-carrier, infected secretion,
saliva, feces, urine, semen, et al., and vertical transmission is transmitted from the
BVDV-carrier to her fetus (Meyling et al. 1990). BVDV infects all ages of cattle, from
fetuses to adult cattle. PI animals are more efficient transmitters than are transient
infected animals because of their long-lasting virus shedding (Larson 2005). Therefore,
the major strategy behind preventing the spread of BVDV is to identify and remove PI
animals. More than 90% of PI cattle were produced due to the BVDV acute infection of
susceptible pregnant female between 45 and 120 days of gestation, and less than 10% of
PI cattle were produced by PI animals that were pregnant (Thomas 2009). To control and
prevent the spread of BVDV, common control programs focus on identification and
removal of PI cattle, biosecurity measures to prevent the import of BVDV, isolation of
new herd additions and avoiding contact with infected feed and instruments, and
vaccination of new calves and heifers/cows to prevent infection of fetuses and calves
(Fulton 2005).
Vaccination is important to prevent the occurrence of PI calves. The effective
vaccine must take into account the diversity of both the antigenic and genetic makeup.
The developed BVDV vaccines include the killed or modified live vaccine (MLV) to
BVDV-1a, BVDV-1b, and BVDV-2a (Cortese et al. 1998; Fulton et al. 1995; Fulton et
al. 2000; Fulton et al. 2002). Over 180 vaccines are based on either BVDV alone or
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BVDV in combination with bovine herpesvirus-1 and parainfluenza virus type 3. Bovine
respiratory syncytial virus was developed and licensed by the USDA, and these vaccines
have been listed in the Compendium of Veterinary Products since 2006. Most of the
vaccines were developed to protect the infection of BVDV-1a from the 1960s to the
1990s. However, the BVDV-1 vaccine is not able to efficiently protect from BVDV-2
infection, and BVDV-1b is the predominant subtype in the United States (Fulton et al.
2000; Fulton et al. 2002; Yan et al. 2011). Moreover, limited BVDV-1b, BVDV-2a
commercial vaccines are available. Due to the increase of the new subtypes, a broadspectrum vaccine is needed to efficiently protect animals from BVDV’s multiple
subtypes. Some companies have attempted to develop either an MLV or a killed BVDV
vaccine with both BVDV-1 and BVDV-2 immunogens.
The BVDV MLV vaccine is similar to other MLV vaccines which require smaller
amounts of virus than killed vaccines, and require only one dose for immunization.
However, the handling of MLV requires more rigid precautions than killed vaccines
because it is susceptible to inactivation by chemicals and/or exposure to higher
temperatures. Although the killed vaccines are safer than the MLV, the efficiency of
killed vaccine is lower than MLV (Fulton 2005). Viruses may be transmitted to the fetus
if the pregnant cow is vaccinated using MLV, therefore, the development of an efficient
and safe MLV is essential for the future.
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CHAPTER III
COMBINATION OF REVERSE TRANSCRIPTION REAL-TIME POLYMERASE
CHAIN REACTION AND ANTIGEN CAPTURE ENZYME-LINKED
IMMUNOSORBENT ASSAY FOR THE DETECTION OF
ANIMALS PERSISTENTLY INFECTED WITH
BOVINE VIRAL DIARRHEA VIRUS1
3.1

Abstract
Bovine viral diarrhea virus (BVDV) is an economically important pathogen of

cattle. A successful control program requires early detection and removal of persistently
infected (PI) animals. The objective of the current study was to develop, validate, and
apply a cost-effective testing scheme for the detection of BVDV persistent infected
animals in exposed herds. Pooled samples were screened by using a real-time reverse
transcription polymerase chain reaction (real-time RT-PCR), and individual positives
were identified with an antigen capture enzyme-linked immunosorbent assay (ACE). The
detection limits of the optimized real-time RT-PCR were 10 and 100 RNA copies per
reaction for BVDV-1 and BVDV-2, respectively. The semiquantitative results of realtime RT-PCR and ACE or real-time RT-PCR and immunohistochemistry were
moderately correlated. The threshold cycle of real-time RT-PCR performed on pooled
samples was significantly correlated with the pool size (R2 = 0.993). The least-cost pool
sizes were 50 at a prevalence of 0.25 - 0.5% and 25 at a prevalence of 0.75 - 2.0%. By
1
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using the combined real-time RT-PCR and ACE procedure, 111 of 27,932 (0.4%)
samples tested positive for BVDV. At this prevalence, cost reduction associated with the
application of real-time RT-PCR and ACE ranged from 61% to 94%, compared with
testing individual samples by ACE, immunohistochemistry, or real-time RT-PCR. Realtime RT-PCR screening also indicated that 92.94% of PI animals were infected with
BVDV-1, 3.53% with BVDV-2, and 3.53% with both BVDV-1 and BVDV-2. Analysis
of the 5'-untranslated region of 22 isolates revealed the predominance of BVDV-1b
followed by BVDV-2a.
3.2

Introduction
Bovine viral diarrhea virus (BVDV) is an economically important pathogen of

cattle worldwide (Houe 1999), and, along with Classical swine fever disease virus
(CSFV) and Border disease virus, is a member of the Pestivirus genus in the family of
Flaviviridae (Lindenbach et al. 2001). The virus has a broad tissue tropism and can infect
many cell types of bovine host (Lindenbach et al. 2001). The 2 biotypes of BVDV,
cytopathic and noncytopathic, are distinguished according to their effects on cultured
cells (Meyers and Thiel 1996). BVDV isolates can be further classified by genotypes,
BVDV-1 and BVDV-2, and subgenotypes on the basis of sequence variations in the 5' untranslated region (UTR) of the viral genome (Ridpath et al. 1994). The BVDV isolates
of either genotypes can have a biotype of cytopathic or noncytopathic, and the
relationship between genotype and pathogenesis remains to be clearly defined (Fulton et
al. 2000). BVDV infection is associated with a diverse array of diseases, including
gastrointestinal disorder, respiratory distress, fetal malformation, stillbirth, abortions, and
mucosal disease (MD) (Baker 1995). Trans-placental infections of the fetuses between 42
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and 125 days of gestation can result in immune-tolerance, and the surviving fetuses
become persistently infected. Persistently infected PI animals continually shed a large
amount of virus in their body secretions and excretions, thereby serving as a reservoir for
BVDV (Baker 1995; Loneragan et al. 2005; McClurkin et al. 1984). Cattle exposed to PI
animals have a higher incidence of respiratory diseases and associated risk for treatment
(Lonergan et al. 2005). Early detection and subsequent removal of PI animals is essential
to a successful disease control program which, however, is often hindered by the high
cost associated with laboratory testing.
Many test methods have been developed for the detection of BVDV, including
virus isolation (VI), immunohistochemistry (IHC), reverse transcription polymerase chain
reaction (RT-PCR), and antigen capture enzyme-linked immunosorbent assay (ACE)
(Afshar et al. 1991; Cornish et al. 2005; Driskell and Ridpath 2006; Saliki et al. 1997;
Sandvik and Krogsrud 1995; Schmitt et al. 1994). Each test has its own strengths and
weaknesses in terms of sensitivity, cost, and turn-around time. Although VI is still
perceived as the criterion standard, it is laborious, time-consuming, and unsuitable for
whole-herd testing (Renshaw et al. 2000; Saliki et al. 1997). ACE is suitable for
screening large numbers of samples; however, the cost for testing individual animals is
relatively high (Driskell and Ridpath 2006; Sandvik and Krogsrud 1995).
Immunohistochemistry detects viral antigens by staining formalin-fixed, paraffinembedded skin biopsies specimens, which is time intensive and can only be applied on
tissue samples (Cornish et al. 2005). Real-time RT-PCR has been widely accepted in
recent years because of its rapid turn-around time and high sensitivity that, in principle,
enables the testing of pooled samples (Bhudevi and Weinstock 2003; Hamel et al. 1995;
Mahlum et al. 2002).
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The objective of the current study was to develop, validate, and apply a costeffective, reliable, and rapid testing protocol for the detection of BVDV PI animals in
exposed herds. To achieve this goal, real-time RT-PCR was optimized to detect
extremely low numbers of BVDV in clinical specimens. Pooled samples were screened
by real-time RT-PCR, and individual positive samples were then identified by ACE. The
validity of the combined real-time RT-PCR and ACE testing scheme was assessed by
performing interest and intersample type comparisons. The least-cost pool sizes were
determined based on the predicted prevalence.
3.3
3.3.1

Materials and methods
Virus and cell culture
BVDV Singer (type 1) and BVDV 125c (type 2) were obtained from the National

Veterinary Services Laboratories (NVSL, Ames, IA). The Madin-Darby bovine kidney
cell line free of BVDV was maintained in minimum essential medium supplemented with
5% horse serum (Sigma-Aldrich, St. Louis, MO) in 75-cm tissue culture flasks. After
inoculation of Madin-Darby bovine kidney cell line with BVDV, the cultures were
incubated at 37°C and observed daily for cytopathic effect. The inoculated cultures that
showed 70-80% cytopathic effect were subjected to a freeze-thaw cycle and low-speed
centrifugation for 10 min at 1,000 × g. The culture supernatants were collected, divided
into aliquots, and then stored at -80°C before use. The virus stocks were titrated in 96well microtiter plates, and the titers (log 50% tissue culture infective dose [TCID50]) were
calculated as previously described (Reed and Muench 1938).
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3.3.2

Sample collection, preparation, and pooling
Serum samples from 899 animals and skin biopsy (ear notch) samples from

27,033 animals submitted to the Mississippi Veterinary Research and Diagnostic
Laboratory (Pearl, Mississippi) between 2006 and 2008 for the diagnosis of bovine viral
diarrhea were used in the present study. Approximately 2 ml of non-hemolytic serum
was taken from each of the original samples for further testing. The ear notches,
approximately 1.25 cm in diameter (0.19 ± 0.02 g), were placed in individual sterile tubes
that contained 2 ml 0.1 M phosphate buffered saline (PBS, pH 7.4), supplemented with
0.02% sodium azide as a preservative. After a brief vortexing (10 sec) and 10-min
incubation at room temperature, the supernatants of the ear notch-PBS suspensions were
collected for further testing. The aliquots of serum and ear notch extracts were
refrigerated at 4°C before being tested by real-time RT-PCR and ACE within one week.
All ACE-positive as well as 50 ACE-negative ear notches were cut into two halves. One
half was fixed in 10% neutral formalin for IHC, whereas the other half, in PBS, was
stored at -80°C for later use. To screen a herd for the presence of BVDV PI animals, the
samples were pooled by mixing equal volumes (200 µl) of sera or ear notch-PBS extracts
from 25 to 50 individual animals of the same herd. The pool sizes (25-50) were chosen
based on 2 factors, the number of samples to be tested and the lowest possible diagnostic
cost per animal. The prevalence (0.5%) data for the year 2005 generated by testing
individual samples were used for cost estimation.
3.3.3

RNA extraction
Two methods were used to extract RNA from different samples. For serum

samples, RNA was extracted from either 200 µl of non-hemolytic individual or 200 µl of
pooled sample by using a commercially available RNA purification system – Trizol
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(Invitrogen Corp., Carlsbad, CA). With ear-notch extracts, cell-cultured BVDV, viral
stocks, and bacterial stocks, RNA was isolated from 500 µl of supernatant by using a
commercial RNA purification kit – RNeasy® Mini kit (Qiagen, Alameda, CA). RNA
extraction was carried out by following the manufacturers’ instructions with minor
modifications (2 additional washes of RNA pellets or columns). RNA was either
resuspended in A or eluted with B in 50 µl of distilled DNase- and RNase-free H2O. The
RNA preparations were stored at -80°C prior to real-time RT-PCR analysis.
3.3.4

Primers and probes
Two sets of primers and probes that target BVDV 5'UTR were derived from

previous publications (Bhudevi and Weinstock 2003; Letellier and Kerkhofs 2003). Two
additional sets of primers and probes that target the same region were designed by using
the Primer Express (Applied Biosystems Inc., Foster City, CA) software. All primers and
probes were commercially synthesized (Qiagen Operon Technologies, Alameda, CA).
Two common primers for BVDV-1 and BVDV-2, and 2 distinct probes capable of
differentiating the 2 genotypes were included in the real-time RT-PCR assay. The 5'ends of the BVDV-1 and BVDV-2 probes were labeled with fluorescent reporter
molecules, 6-carboxyfluorescein (FAM) and cyanine 5 (Cyc5), respectively, whereas the
3'-ends were labeled with the Black Hole Quencher dye (BHQ-1). To clone the 5'-UTR,
primers BVDVLYF 5'TAGCCATGCCCT TAGTAGGAC3' and BVDVLYR
5'CTCCATGTGCCATGTACAGCA ' were used.
3.3.5

Real-time RT-PCR procedure
One-step real-time RT-PCR was performed by using commercial reagents

according to the manufacturer’s instructions (Qiagen Operon Technologies, Alameda,
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CA). The optimal annealing temperature for a given combination of primers and probes
was determined by increasing the temperature from 55°C to 59°C in increments of 1°C.
The optimal concentrations of primers and probes were determined by titration between
0.1 µmol and 1 µmol. The optimal MgCl2 concentration was determined by titration
between 1.5 mM to 2.5 mM. The final volume of real-time RT-PCR was 25 μl, which
contained 8 μl sample RNA and 17 μl of reagent mixture with 2.5 mM MgCl2, 10 mM
deoxyribonucleotide triphosphates, 0.2 μmol of forward primer, 0.2 μmol of reverse
primer, 0.24 μmol of BVDV-1 probe, 0.96 μmol of BVDV-2 probe, 5μmol random
hexamers, 10 U of RNAse inhibitor, and 1 μl of enzymes (Qiagen, Alameda, CA). The
reactions were carried out on a programmable thermocycler Smart Cycler II (Cepheid
Inc., Sunnyvale, CA) as follows: 48°C for 25 min; 95°C for 10 min; 50 cycles of 95°C for
25 s, 56°C for 25 s, 72°C for 30 s; and final elongation at 72°C for 10 min. To avoid
potential contaminations associated with BVDV-contaminated bovine serum, equine
serum was used for cell culture and propagation of viruses. Procedures for sample
processing, PCR reaction set-up, PCR amplification, and cell culture were performed in
separate laboratory sections.
3.3.6

Preparation of BVDV control RNAs
The 5'UTRs of BVDV-1 and BVDV-2 were amplified by PCR and cloned in the

TOPO (topoisomerase I) TA (Taq-amplified) cloning vector (Invitrogen Corp., Carlsbad,
CA) downstream of the T7 promoter to yield plasmids pBVDV-1-5' and pBVDV-2-5',
respectively. The 2 plasmids were linearized with restriction enzyme BamH I and
purified by phenol-chloroform extraction and ethanol precipitation. The control RNA was
transcribed from the T7 promoters by using a T7 RNA polymerase according to the
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manufacturer’s instructions (Applied Biosystems/Ambion, Austin, TX). The transcribed
RNA was purified by using a RNA purification kit – Rneasy® Mini kit (Qiagen,
Alameda, CA) to remove nonincorporated nucleotides and then quantified by
spectrophotometry.
3.3.7

Determination of real-time RT-PCR sensitivity and specificity
The analytical sensitivities were determined by performing real-time RT-PCR

assays by using RNA prepared from the following: 1) 10-fold serial dilutions of BVDV-1
and BVDV-2 stocks, 2) pooled negative ear notch samples (n = 25) spiked with serial
dilutions of viral stocks, 3) 10-fold serial dilutions of in vitro transcribed BVDV-1 and
BVDV-2 5'-UTR RNA, and 4) pooled negative ear samples (n = 25) spiked with serial
dilutions of in vitro transcribed RNA. The input amount of viruses and RNA ranged
from 0.33 to 6.33 log TCID50 or 1 to 8 log RNA copies per reaction. Standard curves
were generated by plotting threshold cycle (Ct) values in the logarithmic linear phase of
amplification against the log TCID50 or log RNA copies. The detection limits of realtime RT-PCR were determined as the last dilution at which all replicate reactions gave
positive results.
The specificity was evaluated by performing real-time RT-PCR by using RNA
extracted from 10-fold serial dilutions (107  10 TCID50 or colony-forming units) of
various bovine pathogens, including Bovine herpes virus-1 (NVSL), Bovine respiratory
syncytial virus (NVSL), Bovine parainfluenza virus-3 (NVSL), Escherichia coli
(American Type Culture Collection [ATCC] 25922), Mycobacterium paratuberculosis
(ATCC 19698), Pastarella multocida (Mississippi Veterinary Research and Diagnostic
Laboratory clinical isolate), Mannheimia hemolytica (ATCC 43270), Arcanobacterium
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pyogenes (ATCC 19411), and Histophilus somni (ATCC 700025). The viral and
bacterial concentrations ranged from 1 to 8 log TCID50 and 1 to 8 log CFU, respectively.
The fluorescent signals of real-timeRT-PCR were analyzed for each organism and
compared to that of BVDV-1 and BVDV-2.
To assess the effect of sample pooling on the sensitivity of real-time RT-PCR,
positive (PCR and ACE) ear-notch extracts (n = 8) were used to artificially contaminate
negative ear-notch pools of different sizes. The pools were created by mixing equal
volumes (100 µl) of ear notch extracts from 1 positive sample and 11, 24, or 49 negative
samples, yielding a final pool size of 12, 25, or 50. Real-time RT-PCR assays were
subsequently carried out by using RNA prepared from these pools.
3.3.8

Antigen capture ELISA and IHC
ACE detection of BVDV in sera and ear notches was conducted by using a

commercially available test kit per manufacturer’s instruction (IDEXX Laboratories,
Westbrook, ME). Immunohistochemistry detection of BVDV antigen was conducted as
described previously (Cornish et al., 2005; Shin and Acland, 2001). Briefly, the ear notch
samples were fixed in 10% neutral formalin for 2-3 weeks, embedded in paraffin, and
sectioned at 5 μm. Tissue sections were treated with proteinase K (Qiagen, Alameda,
CA), followed by incubation with a primary monoclonal antibody against BVDV
(Oklahoma State University, Stillwater, OK), and alkaline-phosphatase reagents
(Biopath, Oklahoma City, OK) per manufacturers’ instructions. The IHC staining was
graded by 2 pathologists by using a 4-point scale system similar to a previously described
study (Shin and Acland, 2001). A consensus grade of the 2 pathologists was assigned to
each sample. In brief, positive results were interpreted as 1 = faint minimal staining, 2 =
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mild staining, 3 = moderate staining, and 4 = marked intense staining. Negative staining
was scored as 0.
3.3.9

Testing scheme and cost structural analysis
For cost-effectiveness, the samples were pooled and screened by real-time RT-

PCR, and individual samples in positive pools were then tested by ACE. The cost for
screening BVDV PI animals was predicted for herd prevalence that ranged from 0.25 to
3.0% as described previously (Muñoz-Zanzi et al. 2000). The costs of the 3 tests,
estimated based on the costs of reagents and labor as well as the actual fees of several
diagnostic laboratories, were as follows: ACE, $4  $8 (average $6); IHC, $3  $7
(average $5); real-time RT-PCR, $25  $45 (average $35); and VI, $20  $40 (average
$30). The cost was assumed to be the same for a given type of test performed on an
individual sample or a pooled sample. The prevalence of BVDV-positive animals in a
herd was assumed to be 0.25%, 0.3%, 0.5%, 0.75%, 1.00%, 1.25%, 1.50%, 1.75%, and
2.00%. The costs for individual real-time RT-PCR and ACE tests were assigned as c and
d, respectively. The prevalence was represented by π. The total number of animals in a
herd was designated as N, the pool size was k, and the number of pools was r, where r =
N/k, with assuming r is an integer. A positive pool was expected to contain at least 1
positive sample. The probability that a pool would test positive was the binomial
probability, ρ = 1- (1-π)^k. Thus, the cost for pools of r was cr + dr [1-(1-π)^k]*k, and
the cost for testing each animal was c/k+d [1-(1-π)^k]. The costs for testing individual
animals for different pool sizes and prevalence rates were determined. The cost
reductions associated with the application of the combined real-time RT-PCR and ACE
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testing scheme, compared with testing individual animals by ACE, IHC, and real-time
RT-PCR were assessed based on the local prevalence and sample pool size used.
3.3.10 Genetic analysis of the field isolates
The 5'UTR of BVDV isolates were PCR amplified and cloned into a TA cloning
vector (Invitrogen Corp., Carlsbad, CA), and sequenced by a commercial sequencing
facility (Qiagen Operon Technologies, Alameda, CA). The sequences of 22 local BVDV
isolates, 23 reference strains (12 BVDV-1 and 11 BVDV-2), 4 reference Border disease
virus strains, and 4 reference CSFV strains were compared. The 5'-UTR sequences were
aligned by using ClustalX version 2.0 (Larkin et al. 2007). Maximum parsimony (MP)
and neighbor-joining analyses were performed by using PAUP* 4.0 Beta as described
previously (Wan et al. 2008). Maximum likelihood tree estimation was evaluated by
using GARLI version 0.951 (Wan et al. 2008). Tree topologies were confirmed between
each of these 3 methods. Bootstrapping support for tree topologies was performed by
using the neighbor-joining method implemented in PAUP* 4.0 Beta with 1,000
replicates.
3.3.11 Statistical analysis
The correlations between real-time RT-PCR Ct values and the input numbers of
BVDV (log TCID50) and between real-time RT-PCR Ct values and the pool sizes (ln
dilution factors) was determined by linear regression analysis by using Excel 2000
software (Microsoft Corp., Redmond, WA). The correlations between different BVDV
diagnostic tests, including real-time RT-PCR, ACE, and IHC, were determined by using
the CORR procedure of SAS 9.1 software (SAS Institude Inc., Cary, NC). The Pearson
correlation coefficient (r) was used as a measure of the strength of correlation, where +1
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indicated a perfect linear correlation and -1 suggested a perfect inverse (negative)
correlation. The criteria for interpreting the strength of correlations were 0.00 to 0.39, no
correlation to weak correlation; 0.40 to 0.70, moderate correlation; and 0.7 to 1.0, strong
correlation. A p-value less than 0.05 indicated statistical significance.
3.4
3.4.1

Results
Sensitivity and specificity of real-time RT-PCR
Of the multiple primers and probes tested, a previously published set of primers

and probes (BVDV-F2/BVDV-PESTR, BVDV-P-1, and BVDV-P-2) (Letellier and
Kerkhofs 2003) demonstrated the highest sensitivity and lowest background noise (data
not shown). These primers and probes were used throughout the current study to amplify
the 5'-UTR of BVDV-1 and BVDV-2. Linear correlations (R > 0.99) were found between
the Ct value and the log TCID50 or log RNA copies. The detection limits of the assay
defined based on virus concentrations were 1.33 log TCID50 per reaction for BVDV-1
and 2 log TCID50 per reaction for BVDV-2. The detection limits on the input RNA copy
numbers were 1 log copies per reaction for BVDV-1 and 2 log copies per reaction for
BVDV-2 (Figure 3.1A). When in vitro transcribed RNA mixed with negative ear-notch
samples, the detection limits were 2 log copies per reaction for BVDV-1 and 3 log copies
per reaction for BVDV-2 (Figure 3.1B). When the real-time RT-PCR assays were
applied on 3 commonly isolated bovine viral pathogens and 6 bacterial strains, no
fluorescent signals were detected, which suggested a satisfactory specificity.
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Figure 3.1

Real-time reverse transcription polymerase chain reaction sensitivity and
linearity for in vitro transcribed 5�-untranslated region RNA (A) and
RNA-spiked ear-notch samples (B)

Notes: Standard curves were obtained by plotting the threshold cycle (Ct) value versus
log RNA copies per reaction. Data shown are the average of 3 independent experiments.
BVDV= Bovine viral diarrhea virus.
3.4.2

Correlation between testing methods
To validate the testing system, the correlations between the semiquantitative

results of 3 methods were determined. Thirty-four archived ACE-positive ear notches
(from positive pools) with sample-to-positive (S/P) ratios that ranged from 0.4 to 1.4
were subjected to real-time RT-PCR analyses. The real-time RT-PCR Ct values were
initially between 34 and 45 for pools that contained those individual positive samples.
The pool sizes were between 25 and 50. After 1-year storage at -80°C and several cycles
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of freeze-thaw, 4 individual samples tested negative by real-time RT-PCR. For
calculation convenience, a Ct value of 50 was assigned to these 4 samples. The Ct values
for the 34 archived individual samples ranged from 29 to 50. For IHC confirmation, ear
notches were fixed in 10% formalin within a week of their arrival to the diagnostic
laboratory and then were processed for microscopic evaluations. Results of the present
study indicated that the BVDV antigen was mainly present in the epithelial cells located
at the epidermis and follicles. No differences in staining pattern and intensity were
observed between infections with genotype 1 and 2 viruses or between infections with a
single genotype and both genotypes. Consensus scores (1 to 4) obtained by 2 pathologists
were assigned to the positive samples. Pearson correlation coefficients (r) and the
probability values (p) showed that the correlations between the semiquantitative results of
real-time RT-PCR and ACE or IHC were moderate and significant (r > 0.4, P<0.05),
whereas the correlation between ACE and IHC was weak (r = 0.338, P = 0.051; Table
3.1). The inverse correlation between Ct values and ACE S/P ratios or IHC grades was in
accordance with the fact that Ct value is inversely related with the amount of input virus
RNA.
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Table 3.1

Strength and significance of correlations between semiquantitative results of
different Bovine viral diarrhea virus
Pearson correlation coefficients (n = 34)
RT-PCR (Ct value) ACE (S/P ratio)
IHC staining grade

Test Methods
Real-time RT-PCR
value)
ACE (S/P ratio)

(Ct

r = 1.000
P = 0.000

r = -0.432
P = 0.004

r = -0.421
P = 0.013

r = - 0.432

r = 1.000

r = 0.338

P = 0.004

P = 0.000

P = 0.051

Notes: RT-PCR = reverse transcription polymerase chain reaction; Ct = threshold cycle;
ACE = antigen capture enzyme-linked immunosorbent assay; S/P ratio = sample-topositive ratio; IHC = immunohistochemistry. Pearson correlation coefficients (r) and the
P value are indicators of the strength and significance of the correlation between 2 tests.
A negative number indicates an inverse correlation between 2 tests. Results from 34
individual samples were subjected to analysis.
3.4.3

Effect of sample pooling on real-time RT-PCR detection of BVDV
Eight PCR-positive ear notches with real-time RT-PCR Ct values that ranged

from 30.54 to 34.10 were diluted with equal volumes of varying numbers of negative earnotch samples to create pools of different sizes. Threshold cycle values for individual
positive samples and the corresponding pools at sizes of 12, 25, and 50 are summarized
in Table 3.2. The changes in Ct versus the changes in sample pool size are presented in
Figure 3.2A. Overall, a linear correlation (R2 = 0.993) was found between the changes in
Ct and Ln pool sizes (Figure 3.2B). At pool sizes of 12 and 25, the average (SD)
increases in Ct were 5.02 ± 0.94 and 6.49 ± 1.53 cycles, respectively. At a pool size of
50, sharp increases in Ct values as well as interest variations for 3 of the 8 samples (nos.
2, 5, and 8) were detected (Table 3.2 and Figure 3.2A).
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Table 3.2

Sample
ID /Pool

Real-time RT-PCR Ct values of individual positive samples before and after
dilutions with negative samples
1

2

3

4

5

6

7

8

30.54±0.5

34.10±1.4

33.35±0.3

31.96±1.7

33.85±1.6

32.21±1.5

31.27±0.5

32.77±0.6

12

34.58±0.7

38.60±2.8

37.32±0.5

37.23±0.9

38.62±0.3

37.57±0.3

36.62±0.4

39.68±2.6

25

36.15±1.2

41.92±2.8

39.39±0.9

38.87±1.4

41.29±0.2

38.53±0.7

39.60±1.1

39.98±2.0

50

38.15±2.0

44.64±4.7

40.86±1.4

39.63±1.7

45.13±4.2

39.12±1.4

40.16±1.6

44.62±4.8

1×

Notes: Data shown are average threshold cycle values and standard deviations of 3
independent experiments with replicate reactions in each assay.

55

Figure 3.2

Effect of sample pooling on threshold cycle (Ct) values for 8 individual
ear-notch samples

Notes: Bars (A) represent the changes in Ct after mixing 1 positive sample with 11, 24,
and 49 negative samples to yield pools of 12, 25, and 50. The line graph (B) indicates a
linear correlation between the increases in Ct value and Ln pool sizes. Data represent the
average of 3 independent experiments.
3.4.4

Prevalence of BVDV
From 2006 to 2008, a total of 27,932 animals were tested for BVDV persistent

infection (Table 3.3). A total of 22,732 samples (ear notch or sera from different
animals) were subjected to real-time RT-PCR screening of pooled samples, followed by
ACE testing of individual samples in positive pools. Approximately 5,300 ear-notch
samples were tested directly by ACE. Immunohistochemistry was used to confirm
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results when it was necessary. Eighty-five of more than 1,000 pools at sizes that ranged
from 25 to 50 tested positive by real-time RT-PCR, and 26 individual ear notches tested
positive by direct ACE. The majority of positive pools contained 1 positive sample that
was subsequently identified by ACE. Of the 85 positive pools, 3 pools (3.53%)
contained 2 positive samples and 1 pool (1.18%) contained 3 positive samples. The
average prevalence of BVDV in Mississippi for a 3-year period was 0.40% with annual
fluctuations of 0.24% to 0.72%, which was similar to previously reported prevalence of
0.3% to 0.5% in the central south United States (Fulton et al. 2009).
Table 3.3

Prevalence of Bovine viral diarrhea virus during a 3-year period

Year

No. of ear notches

No. of sera

No. of total

Prevalence

2006

8,610 (36)

26 (0)

8,636 (36)

0.42

2007

13,001 (31)

357 (1)

13,358 (32)

0.24

2008

5,422 (30)

516 (13)

5,938 (43)

0.72

2009

27,033 (97)

899 (14)

27,932 (111)

0.40

Notes: The total number of samples represents the number of animals being tested. Earnotch and serum samples were derived from different individual animals. The numbers in
parentheses are positive samples.
3.4.5

Cost-effectiveness
The cost effectiveness of the combined real-time RT-PCR and ACE testing

scheme was evaluated for different pool sizes and prevalence rates (Figure 3.3). At all
pool sizes, the cost per animal associated with real-time RT-PCR/ACE increased as the
prevalence increased. The least cost pool size at prevalence of 0.250.50% was 50 and at
a prevalence of 0.752.0% was 25. The second-best pool sizes for different prevalence
were as follows: 100, 0.25%; 25, 0.300.50%; and 50, 0.752.0%. For instance, the cost
per animal at a prevalence of 0.5% with sample pool sizes of 25 and 50 were predicted to
be $2.11 and $2.03, respectively. For an average local prevalence of 0.40%, the
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predicted cost per animal for pools of 25 was $1.97 and for pools of 50 was $1.78.
However, the true prevalence for a given farm or herd was unknown, and the cost per
animal might have deviated slightly from the predicted dollar amount. At an average
prevalence of 0.4%, application of the real-time RT-PCR and ACE screening protocol
could reduce the cost per animal at a pool size of 25 by 67%, 61%, 94%, and 93%,
compared with testing individual animals by ACE, IHC, real-time RT-PCR, and VI,
respectively (Table 3.4).
Table 3.4

Cost reduction associated with the application of combined real-time reverse
transcription (RT-PCR) and antigen capture enzyme-linked immunosorbent
assay (ACE)
Cost of individual test per animal

Pool size (animal per pool)
Cost reduction ($ per animal)
25% (1.97 per

50% (1.78 per

6

67.17

70.33

3-7

5

60.60

64.40

RT-PCR

25-45

35

94.37

94.91

VI

20-40

30

93.43

94.07

Range ($)

Average ($)

ACE

4-8

IHC

Notes: IHC = immunohistochemistry; VI = virus isolation. Cost reduction associated with
the application of RT-PCR and ACE was calculated based on the predicted cost per
animal at pool sizes of 25 and 50.
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Figure 3.3

Cost structural analysis for the combined reverse transcription polymerase
chain reaction and antigen capture enzyme-linked immunosorbent assay
testing scheme.

Notes: Cost per animal was calculated for different sample pool sizes at various
presumed prevalence. The predicted least cost pool sizes are 25 samples per pool at
prevalence from 0.75% to 2.0% and 50 samples per pool at prevalence from 0.25% to
0.5%.
3.4.6

Genetic analysis of BVDV field isolates
Genotyping by real-time RT-PCR showed that 92.94% of PI animals were

infected with BVDV-1, 3.53% with BVDV-2, and 3.53% with both genotypes (1 and 2).
Analysis of the 5'UTR of 22 field isolates suggested that all 18 BVDV-1 isolates
belonged to the BVDV-1b subgenotype, whereas the 4 BVDV-2 isolates fell into the
BVDV-2a subgenotype (Figure 3.4). Genetic variations among the isolates of each
subgenotype were apparent. Within the BVDV-1b subgenotype, MS7 and MS14 were
clustered with the KE strain; MS2 and MS9 were apart from other known strains; MS19
was closely related to the Osloss strain; MS5, MS1, and MS3 were related to the ILLNC
strains; and MS6, MS10, MS8, and MS15, along with CP 7 and PAT, constituted another
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cluster. The BVDV-2b field isolates formed two distinct clusters with MS13 and MS20
more closely related to BVDV2-AU501, and MS4 and MS12 to BVDV-2-890.

Figure 3.4

Phylogenetic analysis of the 5�-untranslated region (UTR) sequences

Notes: The 5'-untranslated region (UTR) sequences of 22 local Bovine viral diarrhea
virus (BVDV) isolates and selected reference strains of BVDV, Border disease virus
(BDV), and Classical swine fever virus (CSFV) were used in the phylogenetic analysis.
The dendrogram was generated by using the maximum parsimony and neighbor-joining
methods. The 22 local BVDV strains belonged to BVDV-1b and BVDV-2a with genetic
variations within each subgenotype.
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3.5

Discussion
Progress has been made in developing PCR-based assays for detection of BVDV

in various clinical specimens (Bhudevi and Weinstock 2003; Hamel et al. 1995; Kennedy
et al. 2006; Letellier and Kerkhofs 2003; Mahlum et al. 2002; Schmitt et al. 1994;
Weinstock et al. 2001; Young et al. 2006). To validate real-time RT-PCR assay in our
author’s laboratory, multiple primers and probes that target the 5'-UTR of BVDV were
compared, and a previously published combination demonstrated the highest sensitivity
and consistency (Letellier and Kerkhofs 2003). By following extensive optimization, the
real-time RT-PCR assay was able to detect low numbers of viruses in viral stocks or in
virus-spiked ear-notch samples. However, the analytical sensitivity determined based on
TCID50 titer could be affected by the viability of the stock virus. To overcome this
inherent limitation, real-time RT-PCR standard curves were constructed by using serial
dilutions of in vitro transcribed 5'-UTR RNA, which again demonstrated high analytical
sensitivities for both BVDV-1 and BVDV-2. In the present study, cell-free specimens
were tested by real-time RT-PCR, which limited the use of housekeeping genes as an
internal positive control. An external control, such as an unrelated RNA virus, could
have been used to spike clinical samples before RNA extraction and RT-PCR as
described previously (Young et al. 2006). Because of concerns about potential crosscontaminations, this technique was not adopted. The performance of the real-time RTPCR was monitored via spiking negative specimens with known quantities of viruses or
in vitro transcribed RNA.
Intra- and interlaboratory studies have shown that real-time RT-PCR, IHC, and
ACE are all suitable for the detection of BVDV PI animals (Cornish et al. 2005; Driskell
and Ridpath 2006). Good correlations have been found between the qualitative results of
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ACE and IHC or IHC and real-time RT-PCR methods (Cornish et al. 2005; Sandvik
2005; Hilbe et al. 2007). In the current study, the qualitative results of these tests were in
100% agreement for all positive samples, which was in accordance with previous reports
(Cornish et al. 2005; Driskell and Ridpath 2006). Further analysis of the quantitative
results revealed a moderate, but significant, correlation between Ct value and S/P ratio or
Ct value and IHC grade, indicating the usefulness of Ct in estimating BVDV load in
specimens. No significant correlation occurred between the ACE S/P ratio and IHC
grade, which might result from the limited capability of ACE to quantify viruses or the
subjective grading system of IHC. The present study did not focus on the impact of earnotch size on the quantitative results of real-time RT-PCR or ACE. A previous study
showed that the amount of virus detected in ear notch extract was not significantly
affected by sample size over a wide weight range (0.75 g and 0.05 g) (Ridpath et al.,
2006). Because the ear-notch samples used in the current study weighed approximately
0.2 g (1.25 cm in diameter), the sample size was reasonably assumed to have minimal
impact on Ct value or S/P ratio.
It has been suggested that RT-PCR can detect individual positive serum or ear
notch samples in pools of 100 or more (Weinstock et al. 2001; Kennedy et al. 2001). The
current study determined the validity of real-time RT-PCR for screening ear-notch pools
by using multiple individual positives to spike negative pools of various sizes. One
interesting observation from the current study was that the real-time RT-PCR Ct values
for most PI animals fell in the range of 30 to 34 (approximately 4.7 to 3.6 log RNA
copies). Theoretically, mixing a weak-positive ear notch of Ct 34 with 99 negative
samples (pool size of 100) would increase the Ct to 41.22, a value considered positive.
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However, the high Ct values and wide intertest variations for 3 of the 8 pools at a size of
50 indicated a risk of false-negative results associated with large pool sizes (≥ 50).
The effect of sample pooling on the cost, sensitivity, and specificity of BVDV
testing has been predicted by using mathematical models (Muñoz-Zanzi et al. 2000;
Muñoz-Zanzi et al. 2006). Cost analysis for the combined real-time RT-PCR and ACE
testing scheme indicated that 50, followed by 25, was the most cost-effective pool size at
prevalences from 0.25% to 0.50%. A comparison of the Ct values for individual
positives in pools of various sizes suggested that pooling 25 samples had the desired
minimal impact on real-time RT-PCR results. In addition, a pool size of 25 was
conducive to ease of laboratory bench operation and data management. At a pool size of
25, a 60-90% reduction in cost per animal could be achieved by using real-time RT-PCR
and ACE, compared with individual sample testing by IHC, ACE or real-time RT-PCR.
Because the true prevalence for a given herd is unknown until it is tested, the actual cost
per animal and cost reduction may deviate slightly from the calculated dollar amount,
depending on the prevalence, the herd size, and the number of animals to be tested
(Muñoz-Zanzi et al. 2000; Muñoz-Zanzi et al. 2006).
By using the combined real-time RT-PCR and ACE procedure, more than 27,000
samples were tested in a 3-year period. Analysis of the data showed that BVDV
prevalence in Mississippi was relatively low, ranging from 0.24% to 0.72. Although the
presence of both BVDV-1 and BVDV-2 in 3 specimens was confirmed by repeated realtime RT-PCR testing, it is unusual to have a dual persistent infection with both
genotypes. One possible explanation for this phenomenon is that these PI animals were
exposed to a second BVDV virus of a different genotype. Analysis of the 5'UTR of 22
isolates revealed the predominance of BVDV-1b followed by BVDV-2a and the absence
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of BVDV-1a, which differed from the previously reported prevalent types in central
south United States (BVDV Ib only) or in southwest United States (Ib followed by Ia and
IIa) (Fulton et al. 2000; Fulton et al. 2009; Vilcek et al. 2001). Although genetic
variations were detected within each subgenotype, 1b or 2a, it was unknown whether
these variations were associated with any antigenic changes. Further study in this area
will provide useful information for formulating successful vaccination programs.
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CHAPTER IV
DETECTION FAILURE OF BOVINE VIRAL DIARRHEA VIRUS-2 BY DIRECT
FLUORESCENT ANTIBODY TEST ON TISSUE SAMPLES FROM ANIMALS
WITH SEVERE CLINICAL DISEASE AND FATAL OUTCOME
4.1

Abstract
Two virulent BVDV strains were successfully recovered from a beef breeding

cow and a beef calf respectively. Infected animals exhibited severe clinical signs
compatible with thrombocytopenia/hemorrhagic syndrome recently reported in North
American. FA test performed on fresh tissues failed to detect BVDV antigen in both
cases. However, viral RNA was detected by real-time RT-PCR on selected tissues from
both animals and genotyped as BVDV-2. Viral antigen was also detected in various cells
of oral mucosa, esophagus mucosa, and Rare peyer’s patches by IHC test. Analysis of
protein motif on E2 glycoprotein revealed motif changes for both M10-3432 and M105347 compared to reference strain 125c. However the potential involvement of these
changes in diagnostic tests or virus pathogenesis remains unknown. Results from IFA
showed sensitivity reduction while cross-neutralization test indicated antigenic changes
on both M10-3432 and M10-5347. Phylogenetic analysis of E2 region grouped both
Mississippi isolates in BVDV-2a, a subtype containing high virulent strains. M10-3432
was clustered nicely with high virulent strain 890 while M10-5347 was clustered with
another high virulent strain CD 87. In conclusion, the results from studying these two
cases suggest a need for periodically reevaluation of the efficacy of various diagnostic
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tests, especially direct FA-based detection of BVDV when virulent BVDV-2 strains are
implicated.
4.2

Introduction
Bovine viral diarrhea virus-1 (BVDV-1) and BVDV-2 along with classical swine

fever virus (CSFV) and sheep border disease virus (BDV) consist of the Pestivirus genus
in the Flaviviridae family (Thiel et al. 2005). With a broad tissue tropism, BVDV
infections are associated with a wide variety of clinical manifestations in cattle, such as
respiratory distresses, diarrhea, reproductive failure, encephalitis, and congenital
abnormities (Baker 1995). Most BVDV infections are mild or subclinical, which are
commonly associated with reduced production and immunosuppression (Baker 1995;
Brownlie et al. 1987; Moerman et al. 1994). Acute BVDV infections usually manifest as
diarrhea and/or respiratory distress (Baker 1995; Brownlie et al. 1987; Moerman et al.
1994). When a susceptible pregnant cow becomes infected, transplacental transmission
can occur. The consequences of fetal infections are embryonic death, abortion, stillbirth,
or congenital abnormities. If the infection occurs in the first trimester of the gestation it
usually leads to immune tolerance to BVDV, thus resulting in the birth of a persistently
infected (PI) calf (Baker 1995). PI animals have no detectable antibodies against BVDV,
but consistently shed the virus in their excretions and secretions, serving as a primary
source of BVDV infections. Therefore, prompt identification and subsequent removal of
PI animal (s) from exposed herds are critical to control and prevention programs (Baker
1995; Brownlie et al. 1987).
BVDV has two biotypes, CP and NCP based on their growth characters on cell
culture (Donis 1995; Kümmerer 2000). The strains isolated from clinical specimens are
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usually NCP whereas CP strains are rare and often co-isolated with NCP strains from
mucosal diseases (Bolin and Ridpath 1998). The clinical manifestations of mucosal
disease are characterized by erosive lesions throughout the digestive tract, profuse
diarrhea, and high mortality (Baker 1995; Brownlie et al. 1987; Moerman et al. 1994).
Phylogenetic analysis based on the 5’ un-translated region (UTR) of BVDV genome has
led to the recognition of genotype 1 and 2 (Ridpath et al. 1994). Each BVDV genotype
can be further divided into subtypes, such as 1a and 1b, or 2a and 2b. The two genotypes
can be also differentiated serologically (Deregt and Prins 1997). BVDV-1 is often
associated with mild or subclinical infections while BVDV-2 is frequently isolated from
outbreaks of hemorrhagic syndrome in North American. Hemorrhagic syndrome is an
acute, severe form of BVDV, which has been documented in dairy herds, beef cattle, and
veal calves (Carman et al. 1998; Goens 2002; Moerman et al. 1994; Pellerin et al. 1994;
Perdrizet et al. 1987; Ridpath et al. 2006). The condition of the disease is marked by
significantly decreased platelet and white blood cell counts (Walz et al. 1999). The
common clinical signs observed include high fever, bloody diarrhea, hemorrhages on
mucus membrane, and eventually sudden death (Baker 1995; Pellerin et al. 1994; Ridpath
et al. 2006). Young calves inoculated with BVDV-2a strain CD 87 or BVDV-2a strain
890 successfully developed the hemorrhagic form of BVD in two independent
experiments (Corapi et al. 1989; Walz et al. 1999). Effort in identification of genetic
markers for virulence of BVDV-2 strain has resulted in limited success and the
underlying mechanism for the emergence of virulent BVDV remains unknown (Pellerin
et al. 1994; Ridpath et al. 2006; Topliff and Kelling 1998; Tussen et al. 1996).
Prevalence of BVDV-2 with its antigenicity distinct from that of BVDV-1 raised the
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concerns about adequate cross-protection of vaccines made of mainly BVDV-1 strain
(Dean 1999).
Genetic diversity is the basis for phenotypic variations and pathogenic
heterogeneities (Hanmers et al. 200; Donis 1995; Kümmerer et al. 2000). Like other
members of the pestiviruses, genetic recombination between different BVDV strains,
between BVDV and other pestiviruses, or even between viral genomic RNA and host cell
RNA can occur (Kümmerer et al. 2000; Jones et al. 2002; Vilcek et al. 2005).
Recombination can result in gene deletion or insertion. High frequency of point mutation
generated in the RNA virus replication has been contributed to the lacking proofreading
by the viral RNA-dependent-RNA polymerase. It is estimated that such point mutation is
readily generated at a frequency of one mutation per virus replication cycle per 10 kb.
The high frequency of mutation during virus replication can result in the production of
quasispecies, an abundance of genetic variants within a single host (Jones et al. 2002).
The E2 gene of BVDV has a hyper variable region that is accountable for the
quasispecies variation (Donis 1995). Because E2 protein is a major glycoprotein
associated with the induction of host immune response as well as attachment process
during virus replication, antigenic changes due to mutations in E2 will have a direct
effect on the efficacy of BVDV vaccination, the sensitivity and integrity of serological
tests, and the pathogenesis of the virus. Previous reports indicated that antigenic
variations had be associated with multiple test failures in detection of BVDV field
isolates by various diagnostic tests, such as immunohistochemistry, ELISA, and
peroxidase-linked antibody assay (PLA assay) (Elahi et al. 1997; Gripshover et al. 2007).
In this study, we report that direct FA with proper controls failed to detect BVDV
antigen on tissue samples in two cases with severe clinical diseases and fatal outcome,
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which are compatible to BVDV hemorrhagic syndrome. Two BVD viruses, M10-3432
and M10-5347, were recovered from tissue pool of respective animal. Our goal was to
investigate the underlying mechanism in which detection failure of direct FA for BVDV
antigen on various tissues by studying the virus distribution in various tissues using
different diagnostic tests and by serologically, genetically, and molecularly characterizing
the two clinical isolates. The results generated from this study will surely help us better
understand how genetic and antigenic diversity among BVDV isolates affect the
performance of diagnostic test, especially direct FA test on fresh tissue specimens.
4.3
4.3.1

Materials and methods
Animals
The first animal was an adult beef breeding cow (M10-3432) that was found dead

and the carcass was submitted to Mississippi Veterinary Research and Diagnostic
Laboratory (MVRDL) for necropsy. Prior to death, the animal developed acute
respiratory signs and bloody diarrhea. The death was the 17th fatality in a herd with forty
animals within a 3-month period of time. A full necropsy was performed and samples
were collected from major organs, including the brain, skin sample from ear, the oral and
esophageal mucosa, the small and large intestine, the mesenteric lymph node, the lung,
the liver, the spleen, and the kidney. The second animal (M10-5347) was a feedlot calf
that exhibited similar clinical signs and died subsequently. The necropsy of the second
animal was performed by the attending veterinarian. Only tissue samples of the lung, the
mesenteric lymph node, and the small intestine were submitted for laboratory diagnosis.
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4.3.2

BVDV reference strains and antisera
BVDV genotype 1 (Singer) and genotype 2 (125c) were obtained from the

National Veterinary Services Laboratories (NVSL) and propagated in MDBK cells as
described previously (Yan et al. 2011). The reference sera against genotype 1 and 2 were
also obtained from NVSL with neutralization titers greater than 16. Anti-BVDV
polyclonal antiserum (porcine origin) that was used to produce anti-BVDV FITC labeled
FA conjugate was obtained from same manufacture (VMRD, Pullman, WA).
4.3.3

Direct fluorescent antibody assay (FA)
Direct FA was performed to detect BVDV, infectious bovine rhinotracheitis

(IBR), bovine parainfluenza type 3 (PI3), bovine respiratory syncytia virus (BRSV), and
blue tongue virus (BT) antigens in tissue specimens. Briefly, cryostat frozen sections of
fresh tissues were cut at 5 µm and fixed in cold acetone for 10 min at room temperature.
Following air drying, the sections were stained with BVDV FA conjugate (VMRD,
Pullman, WA) for 30 min at 37oC and counter-stained with Evens blue. The slides with
tissue sections were mounted and examined under FA microscope. The results were
recorded as positive or negative.
4.3.4

Immunohistochemistry (IHC)
IHC detection of BVDV antigen was conducted as described previously (Yan et

al. 2011). Briefly, the tissue specimens were fixed in 10% neutral buffered formalin,
embedded in paraffin, and sectioned at 5 μm. Following treatment with proteinase K, the
sections were incubated with a monoclonal antibody recognizing both BVDV-1 and 2 for
30 min at 370C. After 3 washes, the sections were incubated with an anti-murine
antibody labeled with alkaline-phosphatase according to the manufacturer’s instructions
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(Biopath, Oklahoma city). After substrate addition the sections were examined under
light microscopy.
4.3.5

Antigen capture enzyme linked immunoabsorbent assay (AC-ELISA)
AC-ELISA was performed to detect BVDV antigen in the ear notch and serum

specimens of the beef cow according to the manufacturer’s instructions (IDEXX, VT).
4.3.6

Virus isolation
BVDV viruses (M10-3432 and M10-5347) were isolated using Madin-Darby

bovine kidney (MDBK) cells as previously described (Yan et al. 2011). Briefly, the tissue
samples (except the intestinal tissues) were pooled and homologized in 10 ml Hank’s
buffered saline solution (HBSS) containing penicillin (100 unit/ml), streptomycin (100
µg/ml), and amphotericin B (2.5µg/ml). The tissue homogenates were clarified by low
centrifugation at 1500 g for 10 minute. 1 ml supernatant from each clarified homogenate
was used to inoculate MDBK cells at 70-90% confluence in T-25 tissue culture flasks.
After 1 hour incubation at 37oC, 5 ml minimum essential medium (MEM) supplemented
with 5% horse serum (V/V) and a final concentrations of penicillin (100 unit/ml),
streptomycin (100 µg/ml), and amphotericin B (2.5µg/ml) was added to each flask. For
negative controls, MDBK cells in T-25 flasks were mock-infected with 1 ml HBSS
followed by addition of 5 ml growth medium. The inoculated flasks were incubated at
37oC in 5% CO2 and inspected daily for 5 days to observe virus induced cytopathogenic
effect (CPE). To detect non-cytopathic BVDV, infected MDBK cells were stained
directly with BVDV antiserum conjugated with fluorescein isothiocyanate (FITC) and
examined under an FA microscopy. To harvest the virus, BVDV-infected MDBK cells
were lysed through one cycle of freeze-thaw and clarified by low-speed centrifugation for
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10 min at 1,500 g. The supernatants of MDBK cell lysates were collected and stored at 80oC until further testing. The virus isolates were titrated in 96-well plates and the titers
(logTCID50) were determined as described by Reed and Muench (1938).
4.3.7

Indirect fluorescent antibody assay (IFA)
MDBK cells were grown to confluent monolayers in 96-well tissue culture plates.

The cells were inoculated with BVDV at a dose of 100 TCID50 per well. BVDV Singer
and the 125c strains were included as positive controls. At 48 hours post inoculation, the
cells were fixed in a mixed solution of acetone and methanol (equal volume, 50 µl/well)
for 10 min at room temperature. The fixed cells were treated with 2-fold serially diluted
porcine anti-BVDV antiserum (25 µl/well) for 30 min at 37oC followed by 3 washes in
FA buffer. The cells were then incubated with anti-porcine IgG conjugated with FITC (25
µl/well) for 30 min at 37oC. After three times washing the stained cells were examined
under an FA microscope.
4.3.8

Serum neutralization assay (SN)
SN assays were performed using a standard microtitration procedure. Briefly,

reference sera were 2-fold serially diluted in a 96-well plate followed by addition of
various testing viruses in an amount of 100 TCID50 per well. After 1 hour incubation
MDBK cells (5,000 /well) were seeded. Plate was incubated at 37oC and cytopathogenic
effect (CPE) was observed daily for a period of five days. For NCP strains, a direct FA
test was used to detect viral antigen. Duplicate wells were included for each serum
dilution and the experiments were repeated 3 times. The neutralization titer was
calculated based on the endpoint dilution, at which 50% cell protection from virus
infection was observed.
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4.3.9

RNA extraction
Viral RNA was extracted from cell culture supernatant using the RNeasy mini kit

according to the manufacturer’s instructions (Qiagen, CA). Total RNA from tissue
homogenates samples were extracted by using TRIzon reagent per manufacturer’s
instructions (Life Technologies, CA). RNA from each sample was eluted in 50 µl of
DNase and RNase-free water and stored at -80oC until use.
4.3.10 Reverse transcriptase polymerase chain reaction (RT-PCR)
One-step real-time RT-PCR was performed to detect BVDV in tissue specimens
and cell culture supernatants as described previously (Yan et al. 2011). Two pairs of
primers were used to amplify the 5'-UTR for sequence determination (Table 4.1). Four
pairs of primers were used to amplify the E2 coding region (Table 4.1). Primers and
probes used in BVDV diagnosis and subsequent genotyping were described previously
(Letellier et al. 2003; Yan at al. 2011). The sensitivity of the real-time RT-PCR in
detecting BVDV clinical isolates was determined. In brief, RNA was extracted from 10fold serial dilutions of each clinical isolate, BVDV-1 reference strain Singer, BVDV-2
reference strain 125c, and in vitro transcribed RNA using plasmid containing 5'UTR
sequences of BVDV-1 or -2. A series of real-time RT-PCR was performed. Standard
curves were generated by plotting threshold cycle values (Ct) in the logarithmic linear
phase of amplification against the log RNA copy number. The detection limits were
determined as the highest dilution at which all replicate reactions gave positive results.
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Table 4.1

Primers of 5'UTR and E2

Targeting
Region

Virus ID

Primer ID

Primer Sequences

Tm (oC)

BVDV1

1F

CTC GTA TAC ATA TTG GAC ACTC

58.9

1R

CTC CAT GTG CCATGTACAGCA

62.57

2F

GTATACGAGATTAGGTAAAGWAC

57.1

2R

CTC CAT GTG CCATGTACAGCA

5'UTR
BVDV2

1E2R1

62.57
GAC CAR ATT GGT GGC CTT ATG AGAC 65.4
CAC YGT GTC CCC TAT CTT GCAT
63.6

1E2F2

GAA GAC CTC TAC GAC TGT GCCT

64.5

1E2R2

CAG TGG GAT CAC GCC TRG CTAT

65.5

2E2F1

GCC ATC AGA GAC TTA ACT AGG

60.6

2E2R1

GGTG TCA TCT ACA TAC CTG TAC

60.8

2E2F2

TCY ATG AAT GCA TTC TDG GWGG

60.5

2E2R2

GTC CAT AGC ACT TTG GTC ATC AG

62.8

1E2F1
BVDV1
E2
BVDV2

Notes: Primers used for amplification of 5�UTR region and E2 coding region by RTPCR. PCR products were cloned in the TOPO TA Cloning® Vector according to the
protocol provided by the manufacturer (Invitrogen, CA) and sequenced from both
directions.
4.3.11 Sequencing the 5�UTR and E2 glycoprotein gene
The 5�UTRs were amplified by PCR and cloned into the TOPO TA Cloning®
Vector according to the manufacturer’s instructions (Invitrogen, CA). Plasmid DNA was
extracted using the DNAesy kit and the inserts were sequenced from both directions
(Eurofins mwg operon, CA). The E2 glycoprotein gene was amplified using primers
listed in Table 4.1. The PCR amplicons with overlapping ends were sequenced from both
directions. Multiple sequence alignment was performed and the full length amino acid
sequence of the E2 genes (approximately 1,116bp) was deduced.
4.3.12 Phylogenetic analysis
E2 amino acid sequences and 5�UTR nucleotide sequence of the clinical isolates
and reference strains were aligned using Muscle program (Edgar 2004). The Genbank
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accession numbers of the reference sequences are listed in Table 4.2. Best-fit model of
the alignments was selected based on the Akaike information criterion (AIC) score, the
best-fit model of nucleotides was selected using the Modeltest3.7 (Posada and Crandal
1998; Posada and Buckley 2004), and the best-fit model of amino acid sequences was
selected using the prottest2.4 (Abascal et al. 2005). Phylogenetic trees were constructed
using the Bayesian and Maximum Likelihood (ML) methods. With the Bayesian
approach, phylogeny was inferred by using the Markov chain Monte Carlo (MCMC)
algorithm (Huelsenbeck and Ronquist 2001). With the ML method, phylogeniy was
inferred using the Phyml as secribed previously (Hanmers et al. 2001). The reliability of
phylogenetic trees were estimated using the bootstrap analysis with 1000 replicates, and
the value of greater than 70% (70/100 for ML and 0.7/1.00 for Bayesian) support the
phylogenetic position.
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Table 4.2

Reference strains used in the phylogenetic tree of E2

Strain name
BVDV2_17237

Accession #
EU747875

Sources
Slovakia

Strain name
BDV_H2121

Accession #
ADK63187

Sources
Germany

BVDV2_Gi_6

AF144612

Germany

BDV_Gifhorn

ADI58614

Denmark

BVDV2_Hokudai

BAJ09450

Japan

CSFV_SWH

AAZ23587

China

BVDV2_8827

ADX31697

USA

CSFV_Alfort

Aab50409

France

BVDV2_8833

ADX31699

USA

BVDV1_Osloss

AAA02769

Belgium

BVDV2_446

ADX31696

USA

BVDV1_VEDEVAC

CAE51342

Hungary

BVDV2_AU501

ABS19605

USA

BVDV1_ILLNC_CP

AAB58571

USA

BVDV2_CD87

AAA98608

Canada

BVDV1_ILLNC_NCP

AAB58572

USA(ND)

BVDV2_XJ_04

ACQ83621

China

BVDV1_ZM95

AAM88294

China

BVDV2_p11Q

AAN78116

Canada

BVDV1_KE9

ABK96992

Germany

BVDV2_Sil_Lke

AAC72815

Canada

BVDV1_M181 22

JN377424

USA

BVDV2_37621

ADX31702

USA

BVDV1_CP7

AAC55984

Germany

BVDV2_IAF_103

ADX31700

Canada

BVDV1_CP7_5A

AAG00378

Germany

BVDV2_793

ADX31701

Indiana

BVDV1_MS15.1

JN377417

USA

BVDV2_NY93

AAM91913

Germany

BVDV1_MS15.2

JN377418

USA

BVDV2_24301

AAC72816

Canada

BVDV1_MS15.3

JN377419

USA

BVDV2_p24515

AAN78117

Ontario

BVDV1_MS15.4

JN377420

USA

BVDV2_1373

AAD38683

USA

BVDV1_MS15.5

JN377421

USA

BVDV2_890/256

AAR24084

Belgium

BVDV1_MS15.6

JN377422

USA

BVDV2_890

AAA82981

USA

BVDV1_MS15.7

JN377423

USA

BVDV2_MS12

JN387139

USA

BVDV1_Singer_Arg

ABP57735

Argentina

BVDV2_Ind141353

AEA08367

India

BVDV1_NADL

AAA42854

USA(IA)

BVDV2_JZ05_1

ACX42224

China

BVDV1_SD1

AAA42860

USA(OH)

BVDV2_M10 5347

JN377415

USA

BVDV1_Oregon_C24V

AAC61755

England

BVDV2_M10 3432

JN377416

USA

BVDV1_8844

ADX31692

USA (IA)

BVDV2_125c

AAC72814

Canada

Notes: Amino acid sequences of the E2 glycoprotein used in phylogenetic analysis were
provided with strain name, GenBank accession number, and the origin of isolation.
4.3.13 Amino acid sequence and protein motif analyses
The E2 glycoprotein amino acid sequences of the isolates were deduced with the
help of nucleotide tool and the protein motifs were analyzed using the protein tools
provided by the SDS Biology Workbench (http://workbench.sdsc.edu).
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4.3.14 Bacterial culture and fecal flotation
Standard aerobic and anaerobic bacterial cultures were setup for the tissue
specimens of both animals. Routine fecal flotation procedures were performed to detect
parasites in the intestinal contents of both animals.
4.3.15 Serological survey
Sera were collected from 10 animals (8 females and 2 males) on the beef breeding
farm where case M10-3432 was originated. The age of the testing animals varied greatly
from 3-month to 10-year old (Table 4.6). Serological assays were performed to detect
antibodies against Blue tongue virus (BTV), bovine rhinotracheitis virus (IBR), and
BVDV. BTV ELISA was performed according to the protocol provided by the
manufacturer of the ELISA kit (IDEXX, VT). IBR and BVDV serum neutralization tests
were performed as described above.
4.4
4.4.1

Results
Pathology
Gross examination of adult beef breed cow (M10-3432) revealed multifocal

shallow erosions and ulcers in the oral cavity predominantly along the soft palate and
tongue. Numerous erosions and shallow ulcers were also present along the entire length
of the esophagus. The lung contained multiple areas of hemorrhage, and the abomasal
mucosa was multifocally reddened (hyperemic). The uterus contains a proximately 5-6
month old bull calf fetus. No significant lesions were observed in the rumen, reticulum,
omasum, small intestine, large intestine, liver, kidney, adrenal gland, spleen, and brain.
With the beef calf (M10-5347), the lung was congested and multifocal hemorrhage was
appreciated. No significant gross lesions were appreciated in mesenteric lymph node and
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intestine tissue samples. Histopathologic examination of the tissues from the beef breed
cow revealed multifocal ulcerative and lymphocytic stomatitis, multifocal ulcerative
esophagitis, moderate eosinophilic and lymphocytic enteritis, multifocal lymphocytic
abomasitis, and multifocal moderate to severe nonsuppurative perivascular encephalitis.
Due to sample autolysis histopathology examination was not performed on tissue samples
from beef calf (M10-5347).
4.4.2

Detection of viral antigen
FA did not detect BVDV or any other major bovine viruses (IBR, PI3, BRSV,

BT) in the lung, oral mucosa, esophagus, brain, spleen, small intestine, liver, and kidney
tissues of the beef cow (Table 4.3A). FA tests for BRSV, BTV, BVDV, and IBR were
also negative for the lung, mesenteric lymph node, and small intestine tissues of the beef
calf (Table 4.3B). However, IHC demonstrated the presence of BVDV antigen in the
epithelial cells lining the tubuloacinar glands of the oral and esophageal mucosa of the
beef cow (Figure 4.1). Positively stained macrophages were also observed in the Peyer’s
patches (M10-3432). BVDV antigen was not detected in the ear notch or serum samples
of the beef cow (M10-3432), indicating that the animal was not persistently infected by
BVDV. Due to the compromised histological structure associated with tissue autolysis,
IHC could not be successfully performed for the beef calf (M10-5347).
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Table 4.3

Detection of BVDV antigen on various tissues by FA, IHC, or ACE
A: M10-3432
Tissue
Lung
Spleen

IHC
-

FA
-

ACE
ND
ND

Esophagus

+

-

ND

+
-

-

ND
ND

±
-

ND

ND
-

Oral
Brain
Intestine
Ear Notch

B: M10-5347
Tissue
Lung
MLN

IHC
ND
ND

FA
-

ACND
ND

Intestine

ND

-

ND

Notes: PP - Peyer’ patches; MLN - Mesenteric lymph node; ± - weak positive; ND: Not
done. Detection of BVDV antigen in various tissue specimens using fluorescent antibody
test assay (FA), immunohistochemistry (IHC), or AC-ELISA (ACE). A.Results for the
beef breeding cow (M10-3432). B. Results for beef calf (M10-5347). IHC was not
performed for M10-5347 due to compromised morphology associated with tissue
autolysis.
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Figure 4.1

BVDV immunohistochemistry staining

Notes: A, oral mucosa. Epithelial cells lining multifocal mucosal glands demonstrated
positive labeling for BVDV antigen. Bar=40 µm. B, oral mucosal gland higher
magnification. C, small intestine. Multiple intestinal crypt epithelial cells and
intraluminal cellular debris demonstrated strong positive labeling for BVDV antigen.
Bar=40 µm. D, Small intestine. Scattered macrophages within deep mucosal
lymphocytic aggregates demonstrated cytoplasmic BVDV antigen immunoreactivity.
Bar=40 µm.
4.4.3

Real-time RT-PCR detection of BVDV isolates
Real-time RT-PCR performed on pooled tissues samples of the lung, oral mucosa,

and esophageal mucosa of the beef cow (M10-3432) was positive for BVDV. Real-time
RT-PCR based genotyping revealed that the virus belonged to genotype 2. Real-time RTPCR did not detect the virus in the tissue specimens of the brain, spleen, kidney, and
small intestine of M10-3432. Real-time RT-PCR also detected BVDV genotype 2 in the
lung tissue of M10-5347. Real-time RT-PCR did not detect the virus in the lymph node
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and small intestine tissue specimens of M10-5347. The detection limit for BVDV 125c is
1.33 log RNA copy number per reaction, 2 log RNA copy number for both M10-3432
and M10-5347 (Figure 4.2). Sequence analysis indicated that single-nucleotide mutations
occurred in primer and probe binding sites, which could be accountable for the reduced
sensitivity of real-time RT-PCR (data not shown). Nonetheless, the real-time RT-PCR
assay was still able to detect low numbers of the BVDV clinical isolates.

Figure 4.2

Standard curves of reference strain 125c and Mississippi isolates M10-3432
and M10-5347

Notes: Standard curves were constructed based on the Ct values obtained from real-time
RT-PCR assays using 10-fold serially diluted, in vitro transcribed 5’-UTR RNA of
BVDV 2 reference strain 125c, isolate M103432, and M105347. Data presented are
geometric means of three independent experiments with duplicate reactions ± standard
deviation. Y axis represents Ct value while X axis stands for RNA copy number.
4.4.4

Virus isolation and phylogenetic characterization
BVDV was isolated from the pooled tissue samples of both animals. Virus

isolation was confirmed by real-time RT-PCR and FA detection of BVDV in inoculated
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MDBK culture supernatant and/or fixed cells. The isolate derived from the breed cow,
designated M10-3432, was NCP isolate. The virus isolated from the beef calf, designate
M10-5347, was CP isoalte. Phylogenetic analysis using amino acid sequence of E2
glycoprotein classified both isolates, M10-3432 and M10-5347, as genotype 2a.
However, the two isolates were further grouped into two distinct small clusters within 2a
cluster. The isolate M10-3432 was closely related to MS12 (BVDV-2) and BVDV-2a
890 with the former being associated with an acute BVDV infection in Mississippi and
the latter being a highly virulence strain isolated from yearling heifer in Canada that died
of an acute uncomplicated BVDV infection (Bolin et al. 1992). The isolate M10-5347
was closely related to BVDV-2a CD 87, another high virulent BVDV 2a strain recovered
from a severe outbreak in dairy herd (Figure 4.3).
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Figure 4.3

Phylogenetic tree inferred from E2 amino acid sequences

Notes: M10-3432 was clustered with high virulence strain 890 while M10-5347 was
grouped with another virulence strain CD87 (highlighted in pink and blue). Both isolates
were clustered together in BVDV-2a group, a subtype containing many virulent BVDV
strains.
4.4.5

IFA sensitivity
Due to failure of FA in detecting BVDV antigen in tissue specimens, IFA was

performed to investigate the reactivity of the isolates to the porcine anti-BVDV
polyclonal antiserum that was used in the direct FA tests. The results showed that the
reference BVDV strains (Singer and 125c) reacted with the antiserum at a dilution of
2,048 x (11 log2). Compared to the reference strains, a 3-log2 reduction in the reactivity
to porcine anti-BVDV serum was observed for M10-5347 and 1 log reduction was found
for M10-3432 (Table 4.4). The data suggested that the two clinical BVDV isolates had
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reduced reactivity to the BVDV antiserum that is used in production of FA conjugate,
which is commercially available to many diagnostic laboratories.
Table 4.4

IFA sensitivity
2^3

BVDV-1

BVDV-2

M10-5347

M10-3432

2^4 2^5

2^6

2^7

2^8

2^9

2^10

2^11

2^12

CC

VC

+

+

+

+

+

+

+

+

+

-

-

+

+

+

+

+

+

+

+

+

+

-

-

+

+

+

+

+

+

+

+

+

+

-

-

+

+

+

+

+

+

+

+

+

+

-

-

+

+

+

+

+

+

+

-

-

-

-

-

+

+

+

+

+

+

+

-

-

-

-

-

+

+

+

+

+

+

+

+

+

-

-

-

+

+

+

+

+

+

+

+

+

-

-

-

+

Notes: Indirect FA was performed to determine the reactivity of BVDV isolates to
porcine anti-BVDV polyclonal antiserum that was used to produce BVDV FA conjugate.
Reactivity was presented as the highest dilution (titer) that was able to detect BVDV
antigen on cell culture. Data presented are geometric means of three independent
experiments with duplicate reactions. CC: cell control; VC, virus control.
4.4.6

Cross-neutralization activity
Anti-BVDV-1 reference serum (NVSL) effectively neutralized the Singer strain, a

reference strain of BVDV-1, with a mean neutralization titer of 149. The anti-BVDV1
serum had no neutralizing activity against 125c, a reference strain of BVDV 2. The
reference serum against BVDV-2 effectively neutralized 125c strain with a neutralization
titer of 64 while it had very limited neutralization ability against the Singer strain
(BVDV-1) with a low titer of 4 (Table 4.5). In contrast to the reference strains, M10-3432
was neutralized by reference sera against both genotype 1 and 2 with a titer of 1024.
M10-5347 could also be neutralized by both types of antisera with neutralization titers of
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64 and 32 for BVDV-1 and BVDV-2, respectively (Table 4.5). The cross neutralization
data indicated that the isolates, although genotypically classified as type 2a, could be
effectively neutralized by antisera against both BVDV-1 and BVDV-2. The cross
neutralization activity with serum against BVDV-1 virus revealed that the strains had
undergone major antigenic variations (Figure 4.4).

Figure 4.4

Antigenic variation detected by cross-neutralization assay

Notes: Antigenic Variation Detected By Cross-Neutralization Assay. Cross neutralization
of BVDV isolates using standard reference antisera. Neutralization tests were performed
using serially diluted antisera against genotype 1 and genotype 2. The neutralization titer
was determined based on the highest dilution of a serum that was able to neutralize 100
TCID50 virus. Data presented are geometric means of three independent experiments with
duplicate reactions ± standard deviation. Note: AS1, anti-BVDV 1; AS2, anti-BVDV 2
reference serum; BVDV 1, Singer strain; and BVDV 2, 125c strain.
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Table 4.5

Serum neutralization titer

BVDV-1

BVDV-1

BVDV-2

BVDV-2

M10-3432

M10-3432

M10-5347

M10-5347

+AS1

+ AS2

+AS1

+AS2

+AS1

+AS2

+AS1

+AS2

149

0

4

64

1024

1024

64

32

Notes: Cross neutralization of BVDV isolates using standard reference antisera.
Neutralization tests were performed using serially diluted antisera against genotype 1 and
genotype 2. The neutralization titer was determined based on the highest dilution of a
serum that was able to neutralize 100 TCID50 virus.
4.4.7

The amino acid sequence of E2 glycoprotein
The E2 glycoprotein consists of 373 amino acid residues with a projected

molecular weight of 42.478 KD. A comparison of the E2 amino acid sequences of the
two isolates with BVDV-2 reference strain (125c) revealed multiple mutations in the E2
genes of M10-3432 and M10-5347. Five unique mutations, highlighted in pink color,
were identified in the E2 protein of M10-5347 (Figure 4.5). These five mutations were
located at positions 29, T to A; 102, L to P; 275, M to L; 281, E to V; and 302, V to G.
Three unique amino acid changes, highlighted in blue color, were identified in the E2
protein of M10-3432. These three amino acid changes were identified at the following
positions: 142, A to V; 164, R to K; and 192, D to A. In addition to above mutations
unique to each isolate, additional changes in amino acid sequences of the E2 gene,
compared to that of the reference strain 125c, were observed for both isolates (Figure
4.5).
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Figure 4.5

E2 amino acid sequence alignments

Notes: Multiple sequence alignment was performed using the ClustalW program of SDS
Biological Workbench (http://workbench.sdsc.edu/). Altered amino acid residues aer
shown in letters while consensus seuqnce was indicated by dots. Alterations unique to
BVDV M10-3432 and M10-5347 are highlighted in pink and blue, respectively.
4.4.8

Protein motifs of the E2 glycoprotein
The protein motifs of the isolates and the reference strain 125c were analyzed.

Five major types of protein motifs was identified in the E2 glycoprotein amino acid
sequence, including the N-glycosylation site, cAMP- and cGMP-dependent protein
kinase phosphorylation site, protein kinase C phosphorylation site, casein kinase II
phosphorylation site, and N-myristoylation site. The E2 protein of M10-3432 possessed 5
N-glycosylation sites, which was one site more than that of BVDV 125c. At meantime,
the E2 protein of M10-3432 lacked two Casein kinase II phosphorylation sites, compared
to BVDV 125c. For M10-5347, its E2 protein missed one casein kinase II
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phosphorylation site and one N-myristoylation site when compared to reference strain
125c that had 5 casein kinase II phosphorylation sites and 4 N-myristoylation sites. The
comparative results were presented in Table 4.6.
Table 4.6

Protein motifs identified in BVDV E2 protein

Protein Motifs

BVDV 125c

Location
BVDV 125c

BVDV 125c

115->119

115->119

115->119

184->188

184->188

184->188

N-glycosylation site
(4)

228->232

228->232

228->232

296->300

296->300

296->300

cAMP- and cGMP-

155->159

155->159

155->159

34->37

34->37

34->37

153->156

153->156

153->156

252->255

252->255

252->255

58->62

58->62

58->62

74->78

74->78

74->78

238->242

238->242

238->242

267->271

267->271

267->271

277->281

277->281

277->281

100->106

100->106

100->106

134->140

134->140

134->140

182->188

182->188

182->188

251->257

251->257

251->257

Protein kinase C
phosphorylation site
(3)

Casein kinase II
phosphorylation site
(5)

N-myristoylation site
(3)

Notes: Protein motifs identified in BVDV E2 protein. Protein motifs identification was
carried out by using protein tool on SDS Biological Workbench
(http://workbench.sdsc.edu/). BVDV 125c, M10-3432, and M10-5347 were included in
the analysis. The type and location of motifs as well as the quantity of the motifs (in
parenthesis) in BVDV 125c are presented. The motifs in E2 protein consisted of Nglycosylation site, cAMP- and cGMP-dependent protein kinase phosphorylation site,
Protein kinase C phosphorylation site, Casein kinase II phosphorylation site, and Nmyristoylation site.
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4.4.9

Bacteriology and parasitology
Routine aerobic bacterial culture isolated Escherichia coli and Clostridium

perferingens from the intestine of beef cow (M10-3432). No bacteria were isolated from
any other tissues of this animal (M10-3432). Light growth of E. coli was isolated from
the intestine, lung, and lymph nodes of the beef calf (M10-5347), suggesting either
postmortem contamination or antemortem bacteremia. No parasite ova/oocystes were
observed in the fecal samples of both animals.
4.4.10 Serological survey
Two weeks after the initial submission of M10-3432, 10 additional serum samples
were collected from the breeding farm and tested for serum antibodies against BVDV,
BTV, and IBR (BHV-1). For BVDV, 8 animals (65FHC, 2A, 3A, 4A, 72, Bull, Blue 15,
and Jersey) were positive with neutralization titers ranging from 4 to 256 and 2 animals
(1A and 5A) were negative. For BT, sera from 8 animals (65FHC, 1A, 2A, 4A, 72, Bull,
5A, and Blue15 were positive and 2 animals (3A and Jersey) were negative. For IBR, 8
animals (65FHC, 1A, 2A, 4A, 72, Bull, Blue15, and Jersey) were positive with titers
ranging from 4 to 64 and 2 animals (3A and 5A) were negative. The complete results are
presented in Table 4.7.
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Table 4.7

Animal
65FHC

Serological survey results from selected animals of farm where case M103432 was originated
Age

BTV-ELISA

10

Sex
Cow

+

16

IBR-SN
+

1A

5

Cow

+

8

+

<4

-

Healthy

2A

heifer

Cow

+

64

+

8

+

Sick

3A

calf

Bull

-

<4

-

4

+

Healthy

4A

5

Cow

+

4

+

4

+

Healthy

72

6

Cow

+

4

+

32

+

Healthy

Bull

5

Bull

+

4

+

256

+

Healthy

5A

4

Cow

+

<4

-

<4

-

Healthy

Blue15

10

Cow

+

8

+

256

+

Healthy

Jersey

4

Cow

-

32

+

8

+

Healthy

64

BVDV-SN
+

Notes
Healthy

Notes: Serological tests were performed to detect antibodies against BVDV, IBR, and
BT. Serum samples were collected from ten animals in the beef breeding farm from
which M10-3432 was originated. The age and sex of each animal are presented. Data
shown are qualitative results of BTV-ELISA and quantitative results (titer) of serum
neutralization (SN) for BVD and IBR.
4.5

Discussion
BVDV is an economically important viral pathogen of cattle. BVDV infection is

associated with a wide range of clinical diseases, including respiratory distresses,
diarrhea, reproductive losses, or the fatal mucosal disease. The infection often suppresses
the host immune system, thereby increasing the susceptibility of the host, especially
calves, to other viral and bacterial agents. In this study, we isolated two BVDV strains
from two animals with severe diseases and fatal outcome. Clinical manifestations in both
cases were compatible to recently described hemorrhagic syndrome. The breeding cow
developed extensive lesions along the gastrointestinal mucosa. Beef calf had bloody
diarrhea and respiratory stress. Initially, FA test was performed on fresh lung tissue as
well as other available tissue samples. With no specific fluorescence observed on
examined tissue sections both cases were recorded as FA negative. However, clinical
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signs and histologic findings strongly suggested BVDV involvement. Subsequently realtime RT-PCR test was performed on the lung tissues and results were positive for both
animals. Although the exact reason for this discrepancy remains unknown we
hypothesized that antigenic changes on surface protein of new isolates, especially E2
glycoprotein, may be to blame for the FA detection failure. Results from serological
studies indeed showed existing antigenic variations compared to reference strain 125c
These antigenic changes, no matter how subtle, will have a direct impact on the efficacy
of FA test. Furthermore, high auto-fluorescence associated with lung tissue can certainly
complicate FA test.
Both isolates were genotyped by real-time RT-PCR as BVDV-2 and phylogenetic
analyses based on E2 glycoprotein amino acid sequence further grouped M10-3432 and
M0-5347 into a BVDV-2a cluster containing many virulent strains isolated recently from
North American (Figure 4.3). M10-3432 is most closely associated with a highly virulent
NCP strain BVDV 890 while M10-5347 is more close to CD87, another high virulent
NCP strain. This is our first time to isolate a high virulent CP strain. To rule out the
possibility that the beef calf could be a PI animal and the severe clinical signs could be
due to mucosal disease we performed multiple tests on all available tissue samples
including lung, mesenteric lymph node and small intestine. No virus was detected by
PCR on mesenteric lymph node and small intestine except lung tissue. To rule out the
possibility of a mixed infection with M10-5374 and an antigenic matching noncytopathic
strain, we examined M10-5347 virus stock by limited dilution. No NCP strain was
identified by FA test after multiple repeats (data not shown).
Antigenic variation associated with diagnostic test failure has been previously
reported (Elahi et al. 1997; Gripshover et al. 2007). To investigate the causes for the
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false negative results of FA in diagnosing two clinical BVDV cases, we examined the
cross-reactivity between each BVDV isolate and the porcine anti-BVDV serum, which is
used to produce FA conjugate by labeling it with FITC (VMRD, WA). The IFA tests did
show a reduced reactivity of the isolates with anti-BVDV polyclonal antiserum,
compared to the standard reference strains, Singer or 125c (Table 4.4). Crossneutralization test using reference sera against BVDV-1 and BVDV-2 revealed that
standard type specific serum reacted to both isolates with about equal strength, therefore
were indistinguishable by the two types of reference sera (Figure 4.4). This phenomenon
could not be explained by potential experimental artifacts because both reference strains,
Singer (BVDV-1) and 125c (BVDV-2), were neutralized specifically by their respective
antisera (Figure 4.4). Together, the reduced reactivity to porcine anti-BVDV antiserum
and the cross neutralization activities suggest that the strains had mutated in the genes
encoding major antigens, such as the E2 glycoprotein that is known to be able to induce
strong immune response.
To determine the genetic basis for the antigenic variations observed in serological
tests, E2 amino acid sequences of both isolates were compared with that of BVDV 125c,
the reference strain for genotype 2. From the sequence analysis, we did identify multiple
mutations that were unique to isolates M10-3432 and M10-5347 respectively. We further
analyzed the secondary structures of the E2 proteins which led to identification of five
types of protein motifs, including N-glycosylation sites, cAMP- and cGMP-dependent
protein kinase phosphorylation sites, protein kinase C phosphorylation sites, casein
kinase II phosphorylation sites, and N-myristoylation sites (Abou-Jaoude et al. 2007).
Mutations in the E2 gene of the two isolates resulted in the addition or loss of two protein
motifs. Compared to the reference strain 125c, M10-3432 had one more N-glycosylation
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site and lost two casein kinase II phosphorylation sites. The isolate M10-5347 lost one
casein kinase II phosphorylation site as well as one N-myristoylation site. Nglycosylation is known as necessary for the proper folding and trafficking of viral
proteins. Alteration or disruption of N-glycosylation sites can affect the survival and
transmissibility of many viruses. Changes in glycosylation can also affect interaction with
cellular receptors, thereby impacting infectivity (Vigerust and Shepherd 2007). A recent
study demonstrated that mutations in N-glycosylation site in the E2 protein of hepatitis C
virus enhanced the infectivity of the virus (Bungyoku et al. 2009). N-terminal Nmyristoylation is an irreversible lipid anchor protein modification process, catalyzed by
the enzyme N-myristoyltransferase (NMT) (Podell and Gribskov 2004; Zha et al. 2000).
During this process, a myristate is covalently liked to N-terminal amino acids, such as an
exposed glycine residue, of nascent polypeptides (Podell and Gribskov 2004; Zha et al.
2000). N-myristoylation is critically involved in signal transduction, apoptosis, as well as
viral pathogenicity. A recent study has demonstrated that myristoylation signal transfer
from large to small envelope proteins can abolish the infectivity of hepatitis delta virus
(Abou-Jaoudé et al. 2007; Maurer-Stroh et al. 2002). Casein kinase II (CKII) is a
ubiquitous and constitutively active serine and threonine (Ser/Thr) protein kinase
implicated in the budding of influenza viruses (Hui and Nayak 2002; Tucker et al. 1991)
and viral transcription of vesicular stomatitis virus (Gao and Lenard 1995; Mathur and
Banerjee 2002). At the present time, it is not known whether alterations in these motifs
have any implications for the pathogenicity of BVDV. Given the important biological
functions associated with these motifs, further investigation is needed to understand what
roles protein motif in E2 glycoprotein play in BVDV pathogenesis, especially Nmyristoylation and CKII phosphorylation motifs.
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A serological survey of the farm where the beef cow (M10-3432) developed
severe clinical signs suggested poor herd immunity as evidenced by the uneven antibody
titers against BVDV, IBR, and BTV. Negative animals and animals with antibody titer
below protection contributed primarily to the poor population immunity, which could
lead to the large number of deaths experienced in the farm. Because persistent infection
was ruled out, the lesions along the oral, esophageal, and intestinal mucosa of the beef
cow were not the result from a “mucosal disease” that is often caused by a mixed
infection of noncytopathic BVDV and cytopathic BVDV in persistently infected animals.
Thus, the virulence of the infecting BVDV should be further investigated.
The genetic and antigenic variations of BVDV have a great impact on the
diagnosis, prevention, and control of the diseases associated with this virus. It is likely
that such variations or diversities will continue to increase due to evolutionary pressures.
Prevention and control of BVDV can be complicated by diagnostic and immunization
failure due to virus diversity. Nevertheless, close monitoring the genetic mutations and
antigenic variations in clinical isolates and frequent evaluation of diagnostic reagents will
provide useful information for the improvement of vaccines and diagnostic tests.

97

4.6

References

1. Abascal F, Zardoya R, Posada D. 2005. ProtTest: selection of best-fit models of
protein evolution. Bioinformatics 21 (9):2104-2105.
2. Abou-Jaoudé G, Molina S, Maurel P, and Sureau C. 2007. Myristoylation signal
transfer from the large to the middle or the small HBV envelope protein leads to a loss of
HDV particles infectivity. Virology 365(1):204-9.
3. Baker JC. 1995. The clinical manifestations of bovine viral diarrhea infection. Vet Clin
North Am Food Anim Pract 11(3):425-45.
4. Bolin SR, Ridpath JF. 1998. Prevalence of bovine viral diarrhea virus genotypes and
antibody against those viral genotypes in fetal bovine serum. J Vet Diagn Invest 10:135–
139.
5. Bolin SR, and Ridpath JF. 1992. Differences in virulence between two noncytopathic
bovine viral diarrhea viruses in calves. Am J Vet Res 53 (11):2157-2163.
6. Brownlie J, Clarke MC, Howard CJ, Pocock DH. 1987. Pathogenesis and
epidemiology of bovine virus diarrhoea virus infection of cattle. Ann Rech Vet.
18(2):157-66.
7. Bungyoku Y, Shoji I, Makine T, Adachi T, Hayashida K, Nagano-Fujii M, Ide YH,
Deng L, Hotta H. 2009. Efficient production of infectious hepatitis C virus with adaptive
mutations in cultured hepatoma cells. J Gen Virol. 90:1681-1691.
8. Carman S, van Dreumel T, Ridpath J, Hazlett M, Alves D, Dubovi E, Tremblay R,
Bolin S, Godkin A, Anderson N. 1998. Severe acute bovine viral diarrhea in Ontario,
1993-1995. J Vet Diagn Invest 10(1):27-35.
9. Corapi WV, French TW, Dubovi EJ. 1989. Severe thrombocytopenia in young calves
experimentally infected with noncytopathic bovine viral diarrhea virus. J. Virol 63 (9):
3934–3943.
10. Dean H, Leyh R. 1999. Cross-protective efficacy of a bovine viral diarrhea virus
(BVDV) type 1 vaccine against type 2 challenge. Vaccine 17(9-10):1117-1124
11. Deregt D, Bolin SR, van den Hurk J, Ridpath JF, Gilbert SA. 1998. Mapping of a
type 1-specific and a type-common epitope on the E2 (gp53) protein of bovine viral
diarrhea virus with neutralization escape mutants. Virus Res 53(1): 81-90.
12. Donis RO. 1995. Molecular biology of bovine viral diarrhea virus and its interactions
with the host. Vet Clin North Am Food Anim Pract 11(3):393-423.
98

13. Edgar RC. 2004. Muscle: multiple sequence alignment with high accuracy and high
throughout. Nucl. Acids Res 32(5): 1792-1797.
14. Elahi SM, Harpin S, Cornaglia E, Talbot B, Elazhary Y. 1997. Antigenic variation
among bovine viral diarrhea virus (BVDV) strains and the role of different cell fixation
methods in immunoassays. Can J Vet Res 61:34-38.
15. Gao Y, Lenard J. 995. Multimerization and transcriptional activation of the
phosphoprotein (P) of vesicular stomatitis virus by casein kinase-II. EMBO J 14(6):12407.
16. Goens SD. 2002. The evolution of bovine viral diarrhea: a review. Can Vet J 43:946954.
17. Gripshover EM, Daniel Givens M, Ridpath JF, Brook KV, Whiteley EM, and Sartin
EA. 2007. Variation in Erns viral glycoprotein associated with failure of
immunohistochemistry and commercial antigen capture ELISA to detect a field strain of
bovine viral diarrhea virus. Vet Microbiol 125:11-21.
18. Guindon S, Gascuel O. 2003. A simple, fast and accurate algorithm to estimate large
phylogenies by maximum likelihood. Syst Biol 52 (5): 696-704.
19. Hamers C, Dehan P, Couvreur B, Letellier C, Kerkhoft P, and Pastoret PP. 2001.
Diversity among bovine pestiviruses. Vet J 161:112-122.
20. Huelsenbeck JP, Ronquist F. 2001. MRBAYES: Bayesian inference of phylogenetic
trees. Bioinformatics 17 (8): 754-755.
21. Hui EK, Nayak DP. 2002. Role of G protein and protein kinase signalling in
influenza virus budding in MDCK cells. J Gen Virol 83:3055-66.
22. Jones LR, Zandomeni R, and Weber EL. 2002. Quasispecies in the 5’ untranslated
genomic region of bovine viral diarrhea virus from a single individual. J Gen Virol
83:2161-2168.
23. Kümmerer BM, Tautz N, Becher P, Thiel H, Meyers G.2000. The genetic basis for
cytopathogenicity of pestiviruses. Vet Microbiol. 77(1-2):117-128.
24. Letellier C, Kerkhofs P, Wellemans G, Vanopdenbosch E. 1999. Detection and
genotyping of bovine diarrhea virus by reverse transcription-polymerase chain
amplification of 5’ untranslated region. Vet Microbiol 64:155-167.
25. Mathur M, Banerjee AK. 2002. Novel binding of GTP to the phosphoprotein (P) of
vesicular stomatitis virus. Gene Expr 10(4):193-200.

99

26. Maurer-Stroh S, Eisenhaber B, Eisenhaber F. 2002. N-terminal N-myristoylation of
proteins: refinement of the sequence motif and its taxon-specific differences. J Mol Biol
317(4):523-40.
27. Moerman A, Straver PJ, de Jong MC, Quak J, Baanvinger T, van Oirschot JT. 1994.
Clinical consequences of a bovine virus diarrhoea virus infection in a dairy herd: a
longitudinal study. Vet Q 16(2):115-9.
28. Pellerin C, van den Hurk J, Lecomte J, Tussen P. 1994. Identification of a new group
of bovine viral diarrhea virus strains associated with severe outbreaks and high
mortalities. Virology 203 (2):260–268.
29. Perdrizet JA, Rebhun WC, Dubovi EJ, Donis RO. 1987. Bovine virus diarrhea–
clinical syndromes in dairy herds. Cornell Vet. 77 (1):46–74.
30. Podell S and Gribskov M. 2004. "Predicting N-terminal myristoylation sites in plant
proteins", BMC Genomics 5:37.
31. Posada D, Buckley TR. 2004. Model selection and model averaging in phylogenetics:
advantage of Akaike information criterion and Bayesian approaches over likelihood ratio
tests. Syst Biol 53(5):793-808.
32. Posada D, Crandall KA. 1998. Model test: testing the model of DNA substitution.
Bioinformatics 14 (9):817-818.
33. Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am J Hyg
27:493-497.

34. Ridpath JF, Bolin SR, and Dubovi EJ. 1994. Segregation of bovine viral diarrhea
virus into genotypes. Virology 205:66-74.
35. Ridpath JF, Bendfeldt S, Neil JD, and Liebler-Tenorio E. 2006.
Lymphocytopathogenic activity in vitro correlates with high virulence in vivo for BVDV
type 2 strains: criteria for a third biotype of BVDV. Virus Research 118:62-69.
36. Ridpath JF, Neill JD, Vilcek S, Dubovi EJ, Carman S. 2006. Multiple outbreaks of
severe acute BVDV in North America occurring between 1993 and 1995 linked to the
same BVDV2 strain. Vet Microbiol 114 (3-4):196-204.
37. Thiel HJ, Collett MS, Gould EA, Heinz FX, Houghton M, Meyers G. 2005.
Flaviviridae. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball BA, editors.
Virus taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses.
San Diego (CA): Elsevier Academic Press. 981-998.
38. Topliff CL and Kelling CL. 1998. Virulence markers in the 5’ untranslated region of
genotype 2 bovine viral diarrhea virus isolates. Virology 250:164-172.
100

39. Tucker SP, Penn CR, McCauley JW. 1991. Characterisation of the influenza virus
associated protein kinase and its resemblance to casein kinase II. Virus Res 18(2-3):243261.
40. Tussen P, Pellerin C, Lecomte J, and van den Hurk J. 1996. Immunodominant E2
(gp53) sequences of high virulent bovine viral diarrhea group II viruses indicate a close
resemblance to a subgroup of border disease viruses. Virology 217:356-361.
41. Vigerust DJ, Shepherd VL. 2007. Virus glycosylation: role in virulence and immune
interactions. Trends Microbiol 15:211-218.
42. Vilcek S, Durkovic B, Kolesarova M, Paton DJ. 2005. Genetic diversity of BVDV:
consequences for classification and molecular epidemiology. Prev Vet Med 72:31-35.
43. Walz PH, Bell TG, Steficek BA, Kaiser L, Maes RK, Baker JC. 1999. Experimental
model of type II bovine viral diarrhea virus-induced thrombocytopenia in neonatal calves.
J Vet Diagn Invest 11:505-514.
44. Yan L, Shuping Zhang, Lanny Pace, Floyd Wilson, Michael Zhang. 2011.
Combination of reverse transcriptase real-time polymerase chain reaction (PCR) and
antigen capture enzyme-linked immunosorbent assay (ACE) for the detection of bovine
viral diarrhea virus (BVDV)-persistently infected animals. J Vet Diagn Invest 23(1): 1625.
45. Zha J, Weiler S, Oh KJ, Wei MC, Korsmeyer SJ. 2000. Posttranslational Nmyristoylation of BID as a molecular switch for targeting mitochondria and apoptosis.
Science 290:1761-1765.

101

CHAPTER V
PHYLOGENETIC ANALYSES OF BOVINE VIRAL DIARRHEA USING THREE
REGIONS 5�UTR, E2, AND NS5B
5.1

Abstract
Bovine viral diarrhea virus (BVDV) is a major viral pathogen affecting

respiratory and reproductive systems of ruminants. BVDV associated infections cause
significant economic losses worldwide. Phylogenetic analysis can be used to estimate the
genetic relationships among different strains, cluster known viruses, and genotype new
isolates. The hyper virulent strains of BVDV associated with hemorrhagic syndrome
discovered in North American in recent years are genotyped as BVDV-2 by phylogenetic
analysis of 5'UTR region. The objective of this study was to conduct comparative
phylogenetic analyses on genetic typing of virulent BVDV isolates using a single region
or concatenated regions of 5'UTR, E2, and NS5B at either nucleotides or amino acids
level. Our results indicated that although slightly difference was observed, the virulent
BVDV isolates were consistently classified into BVDV-2a cluster regardless of date sets
used. Furthermore, phylogenetic tree constructed using combined two or more regions
gave higher posterior probability and bootstrap value than using single region.
5.2

Introduction
Bovine viral diarrhea virus (BVDV) is a major viral pathogen of cattle. BVDV

associated infections cause significant economic losses worldwide. Classical swine fever
virus (CSFV), border disease virus (BDV), BVDV, and tentative giraffe-1 virus are
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members of the genus Pestivirus of the family Flaviviridae, which also includes hepatitis
C virus and flavivirus (Fauquet 2005). The BVDV genome possesses an ORF which was
flanked by 5'UTR (372-385 nucleotides in length) and 3'UTR (229-273 nucleotides in
length) (Collett et al. 1988a; Collett et al. 1988b; Lindenbach et al. 2007). The ORF of
BVDV encodes N-terminal protease fragment Npro, four structural proteins C, Erns, E1,
and E2, and seven nonstructural proteins p7, NS2-3, (NS2), (NS3), NS4A, NS4B, NS5A,
and NS5B. 5'UTR, Npro, E2, NS3 and NS5B of BVDV have been used for phylogenetic
analysis (Baule et al. 1997; Mingala et al. 2009; Oguzoglu et al. 2010; Pellerin et al.;
1994; Ridpath et al. 2000; Vilcek et al. 2001; Wolfmeyer et al. 1997; Xia et al. 2007).
The 5'UTR harbors an internal ribosomal entry site, which is highly conserved among all
members within the genus Pestivirus. But there are three variable loci, which are able to
form a stable and peculiar stem-loop structure for each genotype or species of pestivirus,
thus being used extensively for the characterization of BVDV genotypes (Harasawa
1996; Pestova et al. 1998).
BVDV can be classified into two genotypes BVDV-1 and BVDV-2 based on the
genetic variations of 5'UTR (Ridpath et al. 1994). BVDV-1 can be further divided into at
least 11 subtypes (1a to 1l) based on the phylogenetic analysis of 5'UTR and Npro
(Jackova et al. 2008; Vilcek et al. 2001) while BVDV-2 can be further divided into four
subtypes BVDV-2a, BVDV-2b, BVDV-2c, and BVDV-2d (Giangaspero et al. 2008).
BVDV-1a, 1b and 2a are the major subtypes in North America (Ridpath 2010). A recent
study of phylogenetic analysis on BVDV-1b suggested that BVDV-1b could be further
clustered into 1b1  Osloss and 1b2  CP7 based on the variation of E2. Epidemiological
study indicates that BVDV1b2 is the predominant subtype in the United States (Tajima
and Dubovi 2005).
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E1, E2, and Erns are glycoproteins embedded in viral envelope of BVDV and
induce strong immune response during the course of infection (Meyers and Thiel 1996;
Mingala et al. 2009; Pellerin et al. 1994; Ridpath et al. 1994; Rümenapf et al. 1993;
Tajima and Dubovi 2005). Immunodominant protein E2 is the most variable protein of
pestiviruses, which is the location of the majority of neutralization epitopes and is the
target protein for serological tests to differentiate pestiviruses.
Phylogenetic analysis of pestivirus has been widely used to genotype the new
isolates to understand their evolutionary history. Multiple methods have been used to
construct the phylogeny of a species, and two fundamental approaches have been used
either based on a single genetic element or concatenating multiple genetic sequences.
Several studies have suggested that the phylogenetic tree constructed with concatenated
sequences is considered more stable than phylogenetic trees constructed using a single
region in mammals and many other species (de Queiroz et al. 1995; Gadagkar et al. 2005;
Huelsenbeck et al. 1996; Nei et al. 2001; Yang 1996).
Phylogenetic analysis can be inferred using different methods and most common
methods are distance, maximum parsimony, maximum likelihood (ML), and Bayesian, in
which each methodology has its own uniqueness. Maximum likelihood outputs the
highest probability or likelihood tree by evaluating the differences of tree topologies and
employing all sequence information. Maximum likelihood has a lower variance than
other methods, but is time and memory consuming. The result of maximum likelihood is
dependent on the model of evolution (Aldrich 1997; Cam 1990). Bayesian inference is
closely related to maximum likelihood, but allows the implementation of more complex,
parameter-rich evolution models than maximum likelihood. The prior probability
distribution of the possible trees was assumed in the Bayesian analysis. Markov chain
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Monte Carlo (MCMC) algorithm was used to estimate posterior probabilities in the
Bayesian approach, and posterior probability indicates the reliability of inference (Mar et
al. 2005; Ronquist and Huelsenbeck 2003). Although 5'UTR, E2, and NS5B have been
used in the phylogenetic analysis of BVDV, there is no comprehensive comparison
among these three genes and between nucleotides and amino acids. The objective of this
study is to conduct comparative phylogenetic analyses on virulent BVDV isolates using
single or combined regions (5'UTR, E2, and NS5B) and compare the results achieved
using nucleotide dataset to the results generated from amino acids dataset.
5.3
5.3.1

Materials and methods
Reference strains
Twelve BVDV-1, eleven BVDV-2, two BDV, and two CSFV reference strains

were used in the phylogenetic analyses (Table 5.1). Three regions (5'UTR, E2 and NS5B)
of BVDV references employed in the phylogenetic analyses were downloaded from
GenBank. Three isolates MS12, M10-3432 and M10-5347 were isolated from Mississippi
and M10-3432 and M10-5347 were described in the Chapter IV.
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Table 5.1

Strains used in the phylogenetic analysis

Strain name

Accession # Sources

Strain name

Accession #

Sources

CSFV_SWH

DQ127910

China

BVDV1_Singer

DQ088995

Argentina

CSFV_ Alfort

U90951

France

BVDV1_CP7_5A

AF220247

Germany

BDV_H2121

GU270877

Germany

BVDV2_M10_5347

JN377415

USA (MS)

BDV_Gifhorn

GQ902940

Denmark

BVDV2_MS12

GU395545

USA (MS)

BVDV1_Osloss

M96687

Belgium

BVDV2_M10_3432

JN377416

USA (MS)

BVDV1_ZM95

AF26381

China

BVDV2_JZ05_1

GQ888686

China (CP)

BVDV1_VEDEVAC AJ585412

Hungary

BVDV2_Hokudai

AB567658

Japan

BVDV1_ILLNC_CP

USA (ND) BVDV2_p24515

AY149216

Canada(HVNCP)

BVDV1_ILLNC_NCP U86600

USA(ND) BVDV2_1373

AF145967

USA( IA)

BVDV1_Oregon_c24v AF091605

England

BVDV2_NY93

AF502399

Germany

BVDV1_SD1

M96751

USA OH) BVDV2_p11Q

AY149215

Canada (LVNCP)

BVDV1_CP7

U63479

Germany

BVDV2_XJ_04

FJ527854

China

BVDV1_KE9

EF101530

Germany

BVDV2_890

AAA82981

USA(IA)

BVDV1_NADL

M31182

USA(IA)

U86599

Notes: Two border disease viruses, two classical swine fever viruses, twelve BVDV-1,
and eleven BVDV-2 were downloaded from GenBank. Two BVDV-2 isolates M10-3432
and M10-5347 were isolated from Mississippi and described in the chapter IV.
5.3.2

Primers
5'UTR and E2 of M10-3432, M10-5347, and MS12 were amplified and

sequenced in Chapter IV. Two sets of primers were designed to target NS5B region, and
they are listed in table 5.2. All primers were commercially synthesized and purchased
from Eurofin Operon MWG (Huntsville, AL).
Table 5.2

Primers of NS5B of BVDV-2

Primers

Sequences

Tm (oC)

F1

GA CTT ATA CCA CCT AAT TGG CAG

61.0

R1

GTC CTG GAA TGA ATC CCA TTC

60.6

F2

GAA GCC GGA GAG TTC GTT GAT

62.6

R2

CCA ACA GAG TGA CAC CAG TGT

62.6

Notes: Two sets of primers were designed to target NS5B.
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5.3.3

RNA extraction
Viral RNA was extracted from cell culture supernatant using RNA easy kit

(Qiagen, Valencia, CA) based on the instructions provided by the manufacturer. The
detailed procedures have been described in the Chapter III.
5.3.4

Reverse transcriptase – polymerase chain reaction (RT-PCR) and
sequencing
Two-step RT-PCR was performed using commercial reagents (Qiagen, Valencia,

CA) according to the manufacturer’s instructions. PCR products of the NS5B region of
M10-5347, M10-33432 and MS12 were sequenced by Eurofin Operon MWG
(Huntsville, AL), and the available sequences of these three strains were 1941, 1959 and
1954 nucleotides in length, respectively.
5.3.5

Phylogenetic analysis
Three regions of 5'UTR, structural protein E2, and nonstructural protein NS5B of

BVDV were employed in the phylogenetic analyses based on either nucleotides or amino
acids. For nucleotides, there are three single data sets 5'UTR, E2, NS5B and three
combined data sets 5'UTR+E2, E2+NS5B and 5'UTR+E2+NS5B. For amino acids, there
are two single data sets E2 and NS5B and one combined data set E2+NS5B. Both
nucleotides and amino acids sequences were aligned using Muscle 3.8.31 (Edgar 2004).
Sequence alignments were employed to estimate the best-fit model for each data set,
which were performed using the Modeltest 3.7 for nucleotides (Posada and Buckley
2004; Posada and Crandall 1998), and the Prottest 2.4 for amino acids (Posada and
Buckley 2004) based on Akaike Information Criterion. Phylogenetic analysis was
performed by using Bayesian and maximum likelihood approaches (Mar et al. 2005;
Ronquist et al. 2003; Yang 1996). Bayesian inference estimates the posterior probability
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of phylogenetic trees based on the prior parameters and the likelihood of data, and the
posterior probability supports the branches of phylogenetic tree. The phylogenetic tree
and model parameters values were sampled by using Markov chain Monte Carlo sampler
(Ronquist et al. 2003). Bayesian inference program  MrBayes was used to infer
phylogeny and the average standard deviation of split frequencies less than 0.01 will
achieve a stable tree. MrBayes was performed 1,000,000 generations and sampled the
Markov chain every 1000 generations. The first 25% of trees were discarded as “burn-in”
(Huelsenbeck et al. 1996). Maximum likelihood (ML) outputs the highest likelihood
phylogenetic tree by using all sequence information, and evaluates the different tree
topologies (Aldrich 1997; Cam 1990; Yang 1996). Phyml was used to infer phylogeny
and the reliability of phylogenetic trees was estimated using the bootstrap analysis with
1000 replicates. A bootstrap value greater than 70% (0.7 for posterior probability)
indicated strong support for a branch of the tree (Guindon and Gascuel 2003).
5.4
5.4.1

Results
Model selection
Model tests indicated that GTR+I+G is the best-fit model of nucleotide dataset.

For amino acids, JTT+G+F is the best-fit model of E2 and NS5B, and JTT+I+G+F is the
best-fit model of combined set data of E2+NS5B.
5.4.2

Phylogenetic analyses of BVDV using a single or concatenated regions of
5'UTR, E2, and NS5B
All phylogenetic analyses of a single gene or concatenated regions clearly

classified BVDV into the corresponding groups BVDV-2a, BVDV-1a, 1b1 and 1b2,
which were supported by posterior probability and bootstrap value. Among twelve
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BVDV-1 isolates, Singer, NADL, SD1 and Oregon were classified into BVDV-1a,
VEDEVAC and KE9 were classified into the same branch with BVDV-1b1  Osloss
(Tajima et al. 2001). Among eleven BVDV-2 strains (isolates), all were classified into
BVDV-2a except Hokudai.
5.4.3

Phylogenetic analysis of 5'UTR
Using phylogenetic analysis of 5'UTR, BVDV isolates were classified into

subgroups BVDV-2a, BVDV-1a, 1b1 and 1b2, which were supported by posterior
probability and bootstrap value (Figure 5.1).
All eleven BVDV2 isolates except Hokudai, were classified into BVDV-2a. M103432, NCP high virulence isolate, was clustered into the same branch with MS12
(isolated from the ear notch of a diseased cow in Mississippi, USA) and 890 (a
noncytopathic, high-virulence strain, isolated from a yearling heifer in Iowa, USA) (Bolin
and Ridpath 1992). However, CP high virulence isolate M10-5347 was clustered in
different subgroup from MS12. ILLNC CP and ILLNC NCP isolated from mucosal
disease were classified into the same branch with BVDV-1b2 CP7 (Tajima et al. 2001)
and CP7-5A supported by high posterior probability and bootstrap value (Figure 5.1).
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Figure 5.1

Phylogenetic tree of 5�UTR

Notes: The 5'UTR sequences were aligned using Muscle (Edgar 2004), and the best-fit
model was selected using Modeltest3.7 (Posada and Buckley 2004; Posada and Crandall
1998). Phylogenetic tree of 5'UTR was constructed using Mr.Bayes (Huelsenbeck et al.
1996) and Phyml (Guindon and Gascuel 2003).
5.4.4

Phylogenetic analysis of E2 based on nucleotides and amino acids
Both phylogenetic tree of nucleotides and amino acids of E2 clearly classified

BVDV into the corresponding groups BVDV-2a, BVDV-1a, 1b1 and 1b2, which were
supported by posterior probability and bootstrap value (Figures 5.2A and 5.2B). In both
phylogenetic trees of E2, twelve BVDV-2 isolates except Hokudai were classified into
BVDV-2a, NCP high virulence isolate M10-3432 was clustered into the same branch
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with MS12 (isolated from the ear notch of a cow in Mississippi, USA) and 890 (a
noncytopathic, high-virulence strain, isolated from a yearling heifer in Iowa, USA) (Bolin
and Ridpath 1992). M10-5347, a CP isolate high virulence isolate, was clustered into the
same branch with JZ05_1 CP low virulence strain isolated from China (Li et al. 2010).
ILLNC CP and ILLNC NCP isolated from mucosal disease were classified into the same
branch with BVDV-1b2 CP7 (Tajima et al. 2001) and CP7-5A (Figure 5.2). However,
ILLNC CP and ILLNC NCP were classified into the same branch with BVDV-1b1 
Osloss (Tajima et al. 2001) in the amino acids of E2 (Figure 5.3).

Figure 5.2

Nucleotides tree of E2

Notes: The nucleotides sequences of E2 were aligned using Muscle (Edgar 2004), and the
best-fit model was selected using Modeltest3.7 (Posada and Buckley 2004; Posada and
Crandall 1998). Phylogenetic tree was constructed using Mr.Bayes (Huelsenbeck et al.
1996) and Phyml (Guindon and Gascuel 2003).
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Figure 5.3

Amino acids tree of E2

Notes: The amino acids sequences of E2 were aligned using Muscle (Edgar 2004), and
the best-fit model was selected using Prottest 2.4 (Posada and Buckley 2004).
Phylogenetic tree was constructed using Mr.Bayes (Huelsenbeck et al. 1996) and Phyml
(Guindon and Gascuel 2003).
5.4.5

Phylogenetic analysis of NS5B based on nucleotides and amino acids
Both phylogenetic tree of nucleotides and amino acids of E2 clearly classified

BVDV into the corresponding groups BVDV-2a, BVDV-1a, 1b1 and 1b2, which were
supported by posterior probability and bootstrap value (Figures 5.4and 5.5).
Similarly with phylogenetic trees of 5'UTR and E2, twelve BVDV-2 isolates
except Hokudai were classified into BVDV-2a, NCP high virulence isolate M10-3432
was clustered into the same branch with MS12 (isolated from the ear notch of a cow in
Mississippi, USA) and 890 (a noncytopathic, high-virulence strain, isolated from a
112

yearling heifer in Iowa, USA) (Bolin and Ridpath 1992). Similarly with the phylogenetic
tree of 5'UTR, CP isolate M10-5347 was clustered into a single branch without JZ05_1.
Among the BVDV-1 group, tree topology of NS5B is exactly the same with the tree
topology of E2 in both nucleotides and amino acids trees (Figures 5.4 and 5.5).

Figure 5.4

Nucleotides tree of NS5B

Notes: The nucleotides sequences of NS5B were aligned using Muscle (Edgar 2004), and
the best-fit model was selected using Modeltest3.7 (Posada and Buckley 2004; Posada
and Crandall 1998). Phylogenetic tree was constructed using Mr.Bayes (Huelsenbeck et
al. 1996) and Phyml (Guindon and Gascuel 2003).
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Figure 5.5

Amino acids tree of NS5B

Notes: The amino acids sequences of NS5B were aligned using Muscle (Edgar 2004),
and the best-fit model was selected using Prottest 2.4 (Posada and Buckley 2004).
Phylogenetic tree was constructed using Mr.Bayes (Huelsenbeck et al. 1996) and Phyml
(Guindon and Gascuel 2003).
5.4.6

Phylogenetic analysis of combined E2 with NS5B (E2+NS5B)
Both phylogenetic trees of nucleotides and amino acids sequences of E2+NS5B

clearly classify BVDV strains into the corresponding subtypes BVDV-1a, 1b1, 1b2 and
2a (Figure 5.6). Similarly with other described trees, twelve BVDV-2 isolates except
Hokudai were classified into BVDV-2a, M10-3432 was clustered into the same branch
with MS12 and 890 (Bolin and Ridpath 1992) in the both nucleotides and amino acids
trees. M10-5347 was classified into the same branch with JZ05_1 in the nucleotides tree
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of E2+NS5B, but M10-5347 did not grouped with JZ05_1 in the amino acids tree of
E2+NS5B. Among the BVDV-1 group, tree topology of NS5B was exactly the same with
the tree topology of E2 and NS5B in both nucleotides and amino acids trees (Figures 5.6
and 5.7).

Figure 5.6

Nucleotides tree of E2+NS5B

Notes: The nucleotides sequences of E2+NS5B were concatenated from the nucleotides
sequences of E2 and NS5B. The nucleotides sequences of E2 and NS5B were aligned
using Muscle (Edgar 2004), and the best-fit model was selected using Modeltest3.7
(Posada and Buckley 2004; Posada and Crandall 1998). Phylogenetic tree was
constructed using Mr.Bayes (Huelsenbeck et al. 1996) and Phyml (Guindon and Gascuel
2003).

115

Figure 5.7

Amino acids tree of E2+NS5B

Notes: The amino acids sequences of E2+NS5B were concatenated from the amino acids
sequences of E2 and NS5B. The amino acids sequences were aligned using Muscle
(Edgar 2004), and the best-fit model was selected using Prottest 2.4 (Posada and Buckley
2004). Phylogenetic tree was constructed using Mr.Bayes (Huelsenbeck et al. 1996) and
Phyml (Guindon and Gascuel 2003).
5.4.7

Phylogenteic analysis of concatenated genes 5�UTR+E2 and
5�UTR+E2+NS5B
Both phylogenetic trees of 5'UTR+E2 and 5'UTR+E2+NS5B clearly classify

BVDV strains into the corresponding subtypes BVDV-1a, 1b1, 1b2 and 2a (Figures 5.8
and 5.9). Based on the concatenate 5'UTR+ E2 and 5'UTR+E2+NS5B, the tree topologies
of these two datasets outputted were exactly the same. All taxa were classified into the
corresponding subtypes BVDV-1a, 1b1, 1b2 and 2a. M10-3432 was classified into the
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same group as MS12 and 890 (Bolin and Ridpath 1992), supported by a posterior
probability of 1.00 and a bootstrap value greater than 96 in the phylogenetic tree of both
groups data. M10-5347 was classified into the same group with JZ05_1, supported by a
posterior probability of 1.00 and a bootstrap value greater than 80. Among the BVDV-1
genotype, tree topology of 5'UTR+E2 and 5'UTR+E2+NS5B were similar with the other
tree topology constructed from nucleotides sequences (Figures 5.8 and 5.9). However, all
branches of the phylogenetic tree 5'UTR+E2 supported with the posterior probability
0.97 or higher and the bootstrap value 70 or higher (Figure 5.8). All branches of the
phylogenetic tree of 5'UTR+E2+NS5B supported with posterior probability 1.00 and
bootstrap value 77 or higher (Figure 5.9).
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Figure 5.8

Phylogenetic tree of 5�UTR+E2

Notes: The nucleotides sequences of 5'UTR+E2 were concatenated from the nucleotides
sequences of 5'UTR and E2. The nucleotides sequences of 5'UTR+E2 were aligned using
Muscle (Edgar 2004), and the best-fit model was selected using Modeltest3.7 (Posada
and Buckley 2004; Posada and Crandall 1998). Phylogenetic tree was constructed using
Mr.Bayes (Huelsenbeck et al. 1996) and Phyml (Guindon and Gascuel 2003).
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Figure 5.9

Phylogenetic tree of 5�UTR+E2+NS5B

Notes: The nucleotides sequences of 5'UTR+E2+NS5B were concatenated from the
nucleotides sequences of 5'UTR, E2, and NS5B. The nucleotides sequences of
5'UTR+E2+NS5B were aligned using Muscle (Edgar 2004), and the best-fit model was
selected using Modeltest3.7 (Posada and Buckley 2004; Posada and Crandall 1998).
Phylogenetic tree was constructed using Mr.Bayes (Huelsenbeck et al. 1996) and Phyml
(Guindon and Gascuel 2003).
5.5

Discussion
Phylogenetic analysis is an important approach to classify the new isolates of

pestivirus. Results suggested that phylogenetic trees constructed using concatenated two
or more regions have higher posterior probability and bootstrap value than phylogenetic
trees constructed using a single region. Phylogenetic analysis also indicated that there are
differences in clustering BVDV isolates using different regions of BVDV genome. There
were also differences between nucleotide-based phylogenetic trees and amino acidsbased.
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Phylogenetic analyses of both nucleotides and amino acids and both a single
region or combined regions indicated that Mississippi isolates M10-3432 was clustered
into the same branch with the high-virulence, NCP strain 890 from a yearling calf in Iowa
(Bolin and Ridpath 1992) and Mississippi isolates MS12, isolated from the ear notch of a
cow in Mississippi. Based on amino acid sequence, BVDV-1 strains ILLNC CP and
ILLNC NCP isolated from mucosal disease were closely related with BVDV-1b1 
Osloss; however, these two isolates were closely related with BVDV-1b2-CP7 and CP75A based on nucleotides analysis. ILLNC CP and ILLNC NCP were clustered into
BVDV-1b based on 5'UTR, E2, and NS5B that is consistent with the results reported by
Nagai et al. (2004) based on 5'UTR, Npro, E2, and NS5B-3'UTR. However, ILLNC CP
and ILLNC NCP can be classified into 1a if the NS3 region was used (Xia 2007). Genetic
variations has been reported in NS3 region due to recombination between a pair of
viruses 190 CP and 190 NCP isolated from mucosal disease (Becher et al. 1999; Nagai et
al. 2004).
Mississippi isolates M10-5347 was clustered in the same branch with the lowvirulence, CP strain JZ05_1 in the phylogenetic trees constructed using nucleotides of
concatenated two or three genes and using amino acids of E2. However, M10-5347 was
classified into the separate branch in the phylogenetic trees of 5'UTR and amino acids of
NS5B and E2+NS5B. However, there is slightly different from Tajima and Dubovi’s
(2005) findings that phylogenetic tree of BVDV isolates generated using the E2 region is
similar with the one generated using 5' untranslated region.
Phylogenetic tree of combined three regions 5'UTR, E2, NS5B has the exact same
topology with combined two genes 5'UTR, E2. Tree topology constructed using two or
more regions had higher posterior probability and bootstrap value than constructed from a
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single gene. Our findings are consistent with the study of Xia et al. (2007) based on five
regions (5�UTR, Npro, E2a, E2b, and NS3). The authors suggest that a combined
approach increases the confident placement of new strains in viral classification. Our
results found that the tree topologies of two or three region are more consistent than a
single region. However, the virulence of BVDV was based on clinical description as well
as laboratory data in published data. The consistency of virulence determination by
different laboratories and clinicians may not be the same. Therefore, a standard method a
criteria to determine the virulence of BVDV is needed to help us to understand the
relationship between genotypes and virulence.
The genotype method proposed in this study were solely based on the
phylogenetic analysis of three regions 5'UTR, E2, and NS5B. Previous study
demonstrated that RNA recombination events occurred in BVDV. It is likely the RNA
recombination may affect the tree topology of phylogenetic trees thus the genotypic
results. Due to lack of complete genomic sequences of Mississippi isolates and most
isolates in the public database, RNA recombination were not conducted in this study.
Further study will be needed to assess the presence of RNA recombination events in
BVDV and, if yes, their potential impacts on the genotypic analysis of BVDV.
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CHAPTER VI
CONCLUSIONS
In this dissertation, we have developed a BVDV testing scheme for the detection
of persistently infected animals and characterized two virulent BVDV isolates from
Mississippi herds which failed to be detected using the conventional fluorescent antibody
test. We further used various computational methods to generate phylogenetic trees of
BVDV based on sequences of 5'UTR, E2, and NS5B regions and compare the advantages
and disadvantage of each method.
In the first part, a cost-effective testing scheme by combining real-time RT-PCR
and ACE was developed for the detection of bovine viral diarrhea virus persistently
infected animals in exposed herds. In this testing scheme, pooled samples were screened
using real-time RT-PCR, and individual positives were identified from the positive pools
using ACE. The pool size was estimated based on BVDV prevalence, and the prevalence
of BVDV in Mississippi is 0.4% in a three year period from 2006 to 2008. The least-cost
pool sizes were 50 at a prevalence of 0.25 – 0.5% and 25 at a prevalence of 0.75 – 2.0%.
Also we found the semiquantitative results of real-time RT-PCR and ACE or real-time
RT-PCR and immunohistochemistry were moderately correlated. Real-time RT-PCR
screening also indicated that 92.94% of PI animals were infected with BVDV-1, 3.53%
with BVDV-2, and 3.53% with both BVDV-1 and BVDV-2. Phylogenetic analysis of the
5'-untranslated region of 22 isolates revealed the predominance of BVDV-1b followed by
BVDV-2a.
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In the second part, two virulent BVDV isolates M10-3432 and M10-5347 were
successfully recovered from an adult beef breeding cow and feedlot calf, respectively.
Both isolates were genotyped as BVDV-2 using E2 region. FA failed to detect the
presence of BVDV antigen from fresh tissues of M10-3432 and M10-5347, while crossneutralization test on isolated virus from these two cases indicated antigenic changes on
both M10-3432 and M10-5347. Five unique amino acids from M10-5347 and three from
M10-3432 in E2 region were different from reference strain 125c. Protein motif analysis
of E2 glycoprotein revealed motif changes for both M10-3432 and M10-5347 when
compared to the reference strain 125c. Phylogenetic analysis grouped both Mississippi
isolates in BVDV-2a, a subtype containing high virulent strains. M10-3432 was
clustered with high virulent strain 890 while M10-5347 was clustered with another high
virulent strain CD87.
In the third part, we compared the phylogenetic analyses of BVDV isolates using
a single region or concatenated regions of 5'UTR, E2, and NS5B at either nucleotides or
amino acids level. Although slightly difference was observed, the virulent BVDV isolates
are consistently classified into BVDV-2a cluster regardless of the region used for
analysis. Furthermore, phylogenetic tree constructed using combined two or more regions
were supported with higher posterior probability and bootstrap value than phylogenetic
trees constructed using a single region.
In summary, we provide an effective testing scheme, the combined real-time RTPCR and ACE, to detect persistently infected animals to prevent the spread of the disease.
We also characterize two clinical Mississippi isolates as well as its relationship with other
known isolates/strains to understand the pathogenesis of the disease in Mississippi. We
suggest that using multiple regions of BVDV is a better way to generate a phylogenetic
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tree for typing and grouping. The information from this dissertation will improve the
diagnosis, characterization and prevention of BVDV.
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